Introduction {#s1}
============

Rapidly growing cells typically produce an average of one to two proteins per ribosome per minute ([@bib47]). Both the amount and quality of proteins produced from a cell's transcriptome are crucial for cellular homeostasis ([@bib34]). Thus, cells have evolved numerous mechanisms for regulating translation output ([@bib53]) and monitoring protein quality during and after translation ([@bib72]). One of the earliest monitors of protein quality detects ribosomes that stall during translation ([@bib6]; [@bib27]). A ribosome that slows excessively can be an indicator of several potential problems including a damaged or incorrectly processed mRNA ([@bib62]), amino acid or energy insufficiency ([@bib20]; [@bib24]), or certain types of cellular stress ([@bib35]; [@bib56]). Inability to respond appropriately to these problems leads to disrupted protein homeostasis and disease ([@bib31]).

Because a common cause of ribosome stalling is a defective mRNA, stalled ribosome detection is linked to mRNA decay ([@bib62]) and degradation of the partially synthesised protein ([@bib4]; [@bib27]). There are at least two mechanisms that cells use to detect a stalled ribosome. In the specialised case of an mRNA truncated within the coding region, ribosomes stall at the 3' end with an empty A site that cannot be engaged by either elongation or termination complexes. This allows efficient engagement by the Pelota-Hbs1 complex to initiate a ribosome splitting reaction that separates the peptidyl-tRNA-60S complex from the mRNA-40S complex ([@bib3]; [@bib46]; [@bib58]; [@bib61]). The 60S complex is engaged by ribosome-associated quality control (RQC) factors to trigger polypeptide degradation ([@bib57]), while the 40S complex engages mRNA decay pathways by still poorly-understood mechanisms ([@bib54]).

When a ribosome slows excessively within the coding region, its detection relies on ZNF598 (Hel2 in yeast), an E3 ubiquitin ligase whose ubiquitination of a 40S ribosomal protein (eS10 in mammals or uS10 in yeast) initiates downstream mRNA quality control ([@bib23]) and protein quality control ([@bib15]; [@bib30]; [@bib36]; [@bib67]). The cue used by ZNF598 to recognise a slow ribosome is the collision that occurs when a trailing ribosome catches up ([@bib28]). The collided ribosome shows a distinctive 40S-40S interface where ZNF598/Hel2 is proposed to bind and ubiquitinate nearby target sites ([@bib23]; [@bib28]).

The steps downstream of ZNF598 are incompletely understood and appear to involve nuclease ([@bib13]), a helicase complex ([@bib21]; [@bib36]; [@bib65]), and possibly ribosome rescue factors ([@bib69]). Although the roles and order of action of these factors is only partially resolved ([@bib29]; [@bib37]), the requirement for ZNF598-mediated 40S ubiquitination ([@bib15]; [@bib30]; [@bib36]; [@bib67]) together with the specificity of ZNF598 for ribosome collisions ([@bib28]) strongly argues that the collided ribosome is a key proxy of aberrant translation. Hence, collisions are an upstream event in both mRNA decay ([@bib63]) and nascent protein quality control ([@bib23]; [@bib28]).

Nearly all insight into ribosome stalling and the downstream consequences comes from the analysis of model substrates where specific stalling sequences have been introduced. However, the set of substrates that ordinarily engage RQC are poorly understood. The analysis of RNAs that crosslink to ZNF598 identified mRNAs, tRNAs, and rRNAs, consistent with its engagement of translating ribosome ([@bib15]). Strikingly, the tRNA that was strongly enriched decodes the AAA codon while no specific mRNAs were enriched above others. This observation can be rationalised because ribosomes are well established to stall during translation of poly(A) sequences ([@bib9]) and polyadenylation is known to occur inappropriately at near-cognate sites within the coding region ([@bib18]; [@bib41]; [@bib43]). Thus, prematurely polyadenylated mRNAs are likely to be one physiologically relevant source of ribosome stalling, collisions, and ZNF598 engagement.

While the quality control events downstream of collisions have evolved to eliminate aberrant proteins and mRNAs, promiscuous triggering of these reactions from normal translation complexes would be detrimental. This might be why reticulocytes, which have exceptionally high ribosome densities on highly translated haemoglobin mRNAs, downregulate the collision sensor ZNF598 ([@bib30]; [@bib39]). Indeed, a detectable proportion of ribosomes in native reticulocyte polysomes are collided as judged by their ability to engage exogenously added ZNF598 and resistance to separation by exogenously added nuclease ([@bib30]; [@bib28]).

Unlike the terminally differentiating reticulocyte with a minimal transcriptome and limited life-span, most cells cannot forgo translation quality control. How cells either minimise incidental collisions or avoid promiscuous activation of quality control from them is not clear. Although the precise frequency of incidental collisions is not well established, they are probably not insignificant considering the wide variation in elongation rates ([@bib5]; [@bib25]; [@bib51]; [@bib73]), combined with closely spaced ribosomes on heavily translated mRNAs ([@bib42]). Indeed, recent ribosome profiling experiments examining collided di-ribosomes suggest widespread collisions at numerous (potentially physiologic) pause sites throughout the transcriptome ([@bib1]; [@bib19]; [@bib75]). Here, we have taken an unbiased proteomic approach to identify cellular factors that selectively engage ribosome collisions. In addition to ZNF598, we describe a previously unappreciated response to ribosome collisions that complements the RQC pathway by dynamically adjusting translation initiation.

Results {#s2}
=======

Proteomic identification of collision-specific ribosome interacting factors {#s2-1}
---------------------------------------------------------------------------

We used quantitative proteomics ([@bib49]) to identify ribosome-associating factors recruited selectively to collisions. The poly-ribosome fractions were isolated from cells that were unperturbed, elongation arrested with high-dose emetine, or treated with low-dose emetine to incur widespread collisions ([Figure 1A](#fig1){ref-type="fig"}, inset). Tandem mass tag (TMT) mass spectrometry of these polyribosome fractions identified 598 proteins ([Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}). As expected, core ribosomal proteins were seen to be tightly clustered at the origin (orange circles) providing an internal control for the comparisons ([Figure 1A](#fig1){ref-type="fig"}). Only a handful of the 598 detected proteins were enriched on collided polysomes relative to both untreated polysomes (x-axis) and elongation-arrested polysomes (y-axis).

![Proteomic identification of collision-specific ribosome interacting factors.\
(**A**) Plot of proteins identified by quantitative mass spectrometry in the polysome fraction of cytosol separated by sucrose gradient centrifugation. The cells were either left untreated, treated with low-dose emetine (1.8 µM) to induce collisions (low eme), or treated with high-dose emetine (360 µM) to freeze ribosomes in place (high eme). Pairwise comparisons are plotted such that factors specifically associating with collided ribosomes (i.e., only in low-dose emetine samples) should fall in the upper-right quadrant. Ribosomal proteins are indicated in orange. The position of 3 standard deviations (SD) from the mean along each axis is indicated with a dashed line. Proteins that deviate 3 SD or more along both axes are labelled (in blue and red). (**B**) Cells knocked out for ZNF598 (∆ZNF598) were treated with low or high dose emetine as in panel A and the polysome fractions were analysed by mass spectrometry. These data (x-axis) are plotted relative to the same comparison in wild type cells (y-axis). The position of 3 SD along each axis is indicated with a dashed line, and the data points for the same proteins from panel A are labelled. Note that only EDF1 and GIGYF2 fall into the upper right quadrant in both plots. As expected, ZNF598 was not detected in ∆ZNF598 cells. (**C, D**) Sucrose gradient fractionation and immunoblots of cytosolic lysates prepared from untreated cells versus low-dose emetine treated cells. WT cells were analysed in panel C and ∆ZNF598 cells in panel D. RACK1 is a 40S-ribosomal protein. The positions of fractions containing mono- and polysomes are indicated. Source data are provided for the mass spectrometry analysis.\
Figure 1---source data 1.Proteins identified by mass spectrometry of polysomes.](elife-60038-fig1){#fig1}

ZNF598 was the most enriched collision-specific interaction partner consistent with prior biochemical experiments in vitro and in cells ([@bib28]). To determine whether any of the other enriched proteins might participate in managing collisions via a ZNF598-independent pathway, we analysed ZNF598 knockout (KO) cells. The proteomes of globally stalled (with high-dose emetine) versus globally collided (with low-dose emetine) polysomes showed that only EDF1 and GIGYF2 remained enriched on collided ribosomes ([Figure 1B](#fig1){ref-type="fig"}). Thus, out of almost 600 proteins detected in polysomes, only two were identified to be enriched on collided polysomes relative to both stalled and unperturbed polysomes in both wild type and ZNF598-KO cells. We therefore investigated these further.

Immunoblotting of size-fractionated cytosol showed that both EDF1 and GIGYF2 are primarily observed in non-ribosomal fractions ([Figure 1C](#fig1){ref-type="fig"}). Importantly, long exposures of the blots showed that an estimated 5--10% of both proteins co-fractionated with polysomes. When cells were pre-treated with low-dose emetine, the polysome-associated populations of EDF1 and GIGYF2 sharply increased to 60% and 75%, respectively. Notably, no appreciable population of either protein was enriched in the mono-ribosome fractions. Parallel analysis in ZNF598 KO cells showed very similar fractionation patterns: a minor polysome-associated population of EDF1 and GIGYF2 in untreated cells that increases markedly in cells containing extensive ribosome collisions ([Figure 1D](#fig1){ref-type="fig"}).

Similar results were seen in reticulocyte lysate ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}), which is naturally devoid of ZNF598 due to its downregulation during erythrocyte differentiation ([@bib28]; [@bib39]). Here, collisions were incurred on endogenous haemoglobin mRNAs by allowing elongation in the presence of excess inactive eRF1^AAQ^ to prevent termination at the stop codon ([@bib7]; [@bib28]). The binding of GIGYF2 to collided ribosomes was not via mRNA because its digestion with nuclease did not displace GIGYF2 from collided ribosomes ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). Thus, in two different systems using two different methods to generate ribosome collisions, EDF1 and GIGYF2 are collision-specific ribosome interactors. These results corroborate the unbiased mass spectrometry analysis and establish that GIGYF2 and EDF1 engage ribosome collisions in a ZNF598-independent manner.

GIGYF2 is a collision-dependent cis-acting translational repressor {#s2-2}
------------------------------------------------------------------

Earlier studies have shown that GIGYF2 can inhibit translation initiation by recruiting the alternative cap-binding protein 4EHP (also known as EIF4E2) ([@bib40]; [@bib44]). Recruitment of 4EHP to an mRNA allows it to outcompete the normal cap-binding protein eIF4E to prevent initiation ([@bib10]; [@bib11]). The mRNA targets of GIGYF2 are not well established. Our finding that GIGYF2 is a collision-specific factor suggested the hypothesis that mRNAs containing collided ribosomes are translationally repressed via GIGYF2-dependent 4EHP recruitment. Consistent with this idea, 4EHP was enriched \~1.5 fold on collided ribosomes relative to either normal translating polysomes or non-collided stalled polysomes ([Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}).

To test this idea, we monitored translation output from a reporter mRNA containing a collision-inducing ribosome stalling sequence ([Figure 2A](#fig2){ref-type="fig"}). This reporter contains GFP and a stalling sequence \[21 consecutive lysine-encoding AAA codons, abbreviated as (K^AAA^)~21~\] separated by the viral 2A sequence ([@bib30]). The 2A sequence causes skipping of peptide bond formation with continued downstream elongation, thereby releasing GFP before the ribosome stalls. GFP levels therefore report on the number of translation events without being confounded by any quality control events triggered by stalling. The reporter also contains an RFP positioned after the stall sequence, allowing us to additionally monitor stall-induced disassembly versus read-through (which will be discussed later).

![GIGYF2 is a collision-dependent cis-acting translational repressor.\
(**A**) Schematic representation of the reporter construct containing GFP followed by a viral 2A sequence and either the (K^AAA^)~21~ stall sequence or a (**K**)~0~ control insert that does not stall. (**B**) Flp-In T-REx 293 cells containing the indicated reporter construct stably integrated at a doxycycline-inducible site were treated for 5 days with either non-targeting control siRNAs (gray shaded) or siRNAs targeting GIGYF2 (red traces). The reporter construct was then induced with doxycycline for 20 hr prior to analysis by flow cytometry. GFP-PrP was used as an irrelevant fluorescent protein control to exclude non-specific effects on translation. (**C--E**) Flp-In T-REx 293 cells with stably intergrated (K^AAA^)~21~ reporter were treated with siRNAs targeting GIGYF2 (red traces), 4EHP (blue traces) or control (gray shaded) as in panel A, induced with doxycycline for 20 hr, and analysed by flow cytometry. Panels D and E used cells that were knocked out for GIGYF2 or ZNF598, respectively. GFP expression in all graphs is plotted on a log scale as a histogram and represents around 20,000 cells.](elife-60038-fig2){#fig2}

We found that GIGYF2 knockdown resulted in a \~2.5 fold increase in GFP output from the stalling reporter, but very little effect from a matched reporter lacking the stall sequence ([Figure 2B](#fig2){ref-type="fig"}). This effect could be ascribed to an effect on translation since quantitative RT-PCR showed no obvious effects on mRNA levels ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). The small effect seen with the control reporter was consistently observed, which we suspected was due to a small degree of stalling (and ribosome collisions) at the slowly-decoded 2A sequence ([@bib60]). Consistent with this interpretation, a GFP-tagged protein lacking a 2A sequence showed no effect of GIGYF2 knockdown. Thus, the translation effect of GIGYF2 is substrate-specific and linked to ribosome stalling.

As with GIGYF2, knockdown of 4EHP also resulted in an increase in translation output selectively from the stall-containing reporter ([Figure 2C](#fig2){ref-type="fig"}). The more modest effect of 4EHP may be due to incomplete knockdown ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). Regardless, the effect of 4EHP was dependent on GIGYF2 because no change in translation output was seen with 4EHP knockdown in GIGYF2 KO cells ([Figure 2D](#fig2){ref-type="fig"}). Consistent with GIGYF2 recruitment to collided ribosomes independently of ZNF598, the translational effects of GIGYF2 and 4EHP knockdown were observed in ZNF598 KO cells ([Figure 2E](#fig2){ref-type="fig"}). Considered together, these results indicate that GIGYF2 represses translation initiation via 4EHP consistent with earlier studies demonstrating their interaction ([@bib40]). Because the effects are more prominent on stall-containing ribosomes that incur collisions, we further infer that GIGYF2 primarily operates in cis to inhibit translation from mRNAs to which it is recruited via collided ribosomes.

Effect of EDF1 on frameshifting at stall sites {#s2-3}
----------------------------------------------

The other ZNF598-independent factor that we found to engage collided ribosomes is EDF1, a highly conserved factor found throughout the eukaryotic kingdom and in archaea. Deletion of the EDF1 homolog (Mbf1) in yeast was recently shown to cause increased frameshifting at ribosome stall sequences ([@bib71]). Whether EDF1 has the same function in mammalian cells is not known. The stall sequences used in the yeast system, certain di-codon pairs or a stem-loop, do not detectably stall ribosomes in mammals ([@bib2]; [@bib30]; [@bib67]). Instead, mammalian ribosomes primarily stall on lengthy poly(A) sequences ([@bib2]; [@bib9]; [@bib15]; [@bib30]; [@bib67]). Unfortunately, poly(A) sequences that are sufficiently long to trigger a clear stall, such as (K^AAA^)~21~, also cause extensive frameshifting ([@bib30]). This precluded a clear test of EDF1's role using this stalling sequence.

We therefore tested a shorter poly(A) sequence \[composed of (K^AAA^)~12~\] that causes some stalling, but less baseline frameshifting ([@bib30]). In these three dual-colour GFP-RFP reporter constructs, the C-terminal RFP is appended directly after the poly(A) sequence in each reading frame ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). As documented previously, such a trio of reporters lacking a stalling sequence shows near-undetectable levels of RFP when it is out of frame ([@bib30]). By contrast, the (K^AAA^)~12~ sequence inserted between GFP and RFP allows detectable RFP expression even for the out-of-frame constructs. Relative to the RFP signal for the in-frame construct, \~7% and \~13% signal was seen for the +1 and −1 frame constructs, respectively ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). Upon siRNA-mediated knockdown of EDF1 ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}), little if any increase in the out-of-frame signal was observed ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}).

To determine whether a stronger stall could reveal a role for EDF1 in reading frame maintenance, we turned to stalling sequences derived from human XBP1 ([@bib74]) placed ahead of (K^AAA^)~4~. A set of three reporters each were prepared for wild type XBP1, a stronger-stalling point mutant (S255A), and a weaker-stalling point mutant (W256A mutant) ([Figure 3A](#fig3){ref-type="fig"}). Using the in-frame versions, we confirmed the relative stalling potencies of these XBP1 sequences ([Figure 3B](#fig3){ref-type="fig"}) and verified that the stall-inducing variants are dependent on ZNF598 for aborting translation at the stall ([Figure 3C](#fig3){ref-type="fig"}). ZNF598-dependence indicates that ribosome collisions occur effectively at the stall-inducing sequences. Conversely, the ZNF598-independence of XBP1(W256A) indicates reduced or no collisions at this sequence, providing a negative control for frameshifting experiments.

![Effect of EDF1 on frameshifting at stall sites.\
(**A**) Schematic representation of the reporter constructs used to analyse frameshifting. RFP was directly appended to each of the three tested XBP1 reporters (see amino acid sequences below) in three different reading frames. Note that S255A mutation exacerbates, whereas W256A reduces ribosomal stalling, relative to the wild type XBP1 sequence. (**B**) In-frame versions of the constructs from panel A were co-transfected with BFP-encoding plasmid into Flp-In T-REx 293 cells and analysed by flow cytometry after 20 hr of transgene expression. At least 20,000 transfected (BFP-positive) cells were analysed here and in all the subsequent experiments involving frameshifting reporters. The RFP:GFP ratio, an indicator of readthrough at the XBP1 sequence, is plotted as a histogram for each reporter. (**C**) The same in-frame constructs as in panel B were analysed in WT and ZNF598 KO cells. Note that the RFP:GFP ratio is elevated in ∆ZNF598 cells for WT XBP1 and XBP1(S255A), but not for XBP1(W256A). (**D**) XBP1(S255A) (left) or XBP1(W256A) (right) was transfected into cells pre-treated for 72 hr with non-targeting siRNA (control) or EDF1-targeting siRNA and analysed by flow cytometry after 20 hr of reporter expression. Expression of GFP (bottom panels) and RFP (top panels) was plotted as histograms. Gray shaded traces represent cells positively transfected with in-frame (+0) constructs, blue traces represent −1 constructs and red traces represent +1 constructs. Background fluorescence observed in non-transfected cells is indicated by the unshaded thin gray traces. The amount of RFP signal observed for out-of-frame constructs (+1,--1), represented as a percentage of the in-frame signal, is indicated above each graph. Note that GFP expression is not influenced by the RFP reading frame.](elife-60038-fig3){#fig3}

Comparison of the three-frame set of non-stalling XBP1(W256A) reporters showed RFP signals of \~2% and \~9% in the +1 and −1 frames, respectively, relative to the in-frame construct ([Figure 3D](#fig3){ref-type="fig"}). This is consistent with some degree of frameshifting at the intrinsically 'slippery' (K^AAA^)~4~ sequence, as expected from earlier studies ([@bib2]; [@bib32]). Of note, this level of frameshifting is less than (K^AAA^)~12~, as expected (compare to [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). Parallel analysis of the strong-stalling XBP1(S255A) constructs showed out-of-frame signals of 8% and 15% in the +1 and −1 frames, respectively ([Figure 3D](#fig3){ref-type="fig"}). This indicates that collisions enhance the extent of frameshifting. Similar results were seen for the medium-stalling XBP1 reporters ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}).

Upon knockdown of EDF1, the frameshifting frequency did not change appreciably for the non-stalling XBP1(W256A) reporter but clearly increased in the −1 frame for both the medium-stalling XBP1 and strong-stalling XBP1(S255A) reporters ([Figure 3D](#fig3){ref-type="fig"}, and [Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}). Notably, no obvious increase in the +1 frame was observed for these reporters in EDF1 knockdown cells. Similar results were seen for an independent siRNA that also depletes EDF1 effectively ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}). Of note, the GFP signal, indicative of mRNA levels and reporter translation, is very similar for the three different reading frame reporters within any experiment. Thus, nonsense-mediated decay, which in mammals typically requires an exon junction complex downstream of a premature stop codon ([@bib62]), is not appreciably influencing our observations.

Our observations in mammalian cells roughly approximate recent observations in the yeast system: an increase in frameshifting at stalling sequences ([@bib64]; [@bib71]), which is enhanced by loss of Mbf1 ([@bib71]). Nevertheless, the systems clearly differ. Whereas yeast show a dramatic \~300 fold increase in frameshifting without Mbf1 in some cases, the absence of EDF1 had rather modest consequences even downstream of a strong stalling sequence. Furthermore, the shifted frame that is preferred is also different: +1 in the case of di-codon triggered stalls in yeast versus −1 in the case of Xbp1-mediated stalling in mammalian cells. The basis of these differences may lie in the nature of the sequences used to cause stalling or differences between yeast and mammalian cells. The mode of stalling is likely to be at least part of the explanation because even within yeast, stalling caused by a stem-loop results in both −1 and +1 frameshifting, whereas stall-inducing di-codons result in +1 frameshifting. Additional work is needed to investigate the mechanistic basis of frameshifting at stalls in both yeast and mammals.

EDF1 facilitates GIGYF2 function at collided ribosomes {#s2-4}
------------------------------------------------------

While the physical interactions and consequences on frameshifting place EDF1's function at the ribosome, its molecular role there is unclear. Using our translational reporter assay, we observed that EDF1 knockdown modestly increased translation of a stall-containing mRNA, but had no effect on the control mRNA ([Figure 4A](#fig4){ref-type="fig"}). Increased translation with EDF1 knockdown was not ZNF598-dependent, but was completely lost in GIGYF2 KO cells. The combined knockdown of EDF1 and GIGYF2 was no greater than GIGYF2 alone ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). These observations suggested that EDF1 has no effect on translation rates independently of GIGYF2; instead, EDF1 seems to facilitate GIGYF2 function.

![EDF1 facilitates GIGYF2 function at collided ribosomes.\
(**A**) The indicated cell lines bearing stably integrated translation reporters were treated with the indicated siRNAs for 72 hr. After additional 20 hr of doxycycline-induced reporter expression, cells were collected and analysed by flow cytometry. Histograms representing GFP expression were plotted on a logarithmic scale. (**B**) WT cells (left panel) and ∆EDF1 cells (right panel) were treated with low dose emetine (1.8 µM) for 1 hr and their cytosolic extracts were analysed by sucrose gradient centrifugation followed by western blotting. The profiles of GIGYF2 across the gradient, quantified by densitometry, are depicted below the blots. (**C**) Radiolabelled and immunopurified WT EDF1 or R85G mutant EDF1 produced by in vitro translation was added to separate non-labelled in vitro translation reactions in which ribosomes on native globin mRNA were stalled and collided at the stop codon with eRF1^AAQ^. The samples were then separated by sucrose gradient centrifugation and EDF1 detected by autoradiography. Note that almost 100% of the WT EDF1 comigrates with collided ribosomes, whereas only \~40% of the R85G mutant is found in polysomal fractions with remainder at the top of the gradient. (**D**) ∆EDF1 cells with a stably integrated stalling reporter were transfected with a control plasmid (expressing BFP; shaded gray), WT EDF1 (green traces) and R85G EDF1(blue traces) and expression of transgenes was allowed for 24 hr. After additional 20 hr of doxycycline-induced expression of the stalling reporter, GFP expression was analysed by flow cytometry. Note that only WT, but not the R85G mutant reduces the expression of GFP to the level comparable to WT cells.](elife-60038-fig4){#fig4}

Consistent with this idea, GIGYF2 interaction with polysomes was diminished in cells lacking EDF1 ([Figure 4B](#fig4){ref-type="fig"}). When EDF1 KO cells were treated with low-dose emetine to induce collisions, GIGYF2 was detectable but muted relative to WT cells. Reduced stability of GIGYF2 on collided ribosomes explains why loss of EDF1 partially phenocopies the GIGYF2 KO and why the combined loss is no different from loss of GIGYF2 alone.

Mutagenesis of Mbf1 in yeast has identified several point mutations impaired in its frameshifting suppression activity ([@bib71]). To determine whether this phenotype might be related to its function at collided ribosomes, we tested whether the strongest of these mutants in EDF1 (R85G) influences ribosome binding. In vitro translated and affinity purified radiolabelled EDF1 was found to quantitatively engage collided ribosomes, but not monosomes, in reticulocyte lysate ([Figure 4C](#fig4){ref-type="fig"}). EDF1(R85G) showed substantially impaired interaction with collided ribosomes, with only \~40% co-fractionation.

WT EDF1, but not EDF1(R85G), rescued the stall-dependent translation phenotype in EDF1 KO cells ([Figure 4D](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). Thus, recruitment of EDF1 to collisions is important for its function in translational suppression via GIGYF2. Given the specificity of EDF1 interaction for collided ribosomes ([Figure 1](#fig1){ref-type="fig"}), the specificity of its frameshifting suppression on stalling sequences ([Figure 3](#fig3){ref-type="fig"}, [@bib71]), and the correlation between collisions and frameshifting ([@bib64]), it is attractive to posit that stall-induced collisions, frameshifting, and translation suppression are all mechanistically related.

In this view, collisions can increase the probability of frameshifting. EDF1 functions to reduce collision frequency by attenuating initiation frequency via GIGYF2-4EHP. Consistent with this idea, frameshifting at stall-induced collisions can be relieved by artificially suppressing the rate of translation initiation ([@bib64]). Thus, the robust stall-induced frameshifting seen in yeast lacking Mbf1 may be a consequence of its exceptionally high translation rate during log-phase growth incurring a high rate of collisions. The role of Asc1 and Rps3 in suppressing frameshifting ([@bib71]) might therefore be related to these proteins being needed for Mbf1 recruitment to collisions. Indeed, both proteins are located at the disome interface ([@bib23]; [@bib28]). This working model warrants greater analysis.

ZNF598 and GIGYF2 mediate alternate responses to ribosome collisions {#s2-5}
--------------------------------------------------------------------

To understand the relationship between the collision sensor EDF1 and collision-specific effectors ZNF598 and GIGYF2, we first analysed their physical interactions using co-immunoprecipitation (IP). Earlier studies had shown interactions between ZNF598, GIGYF2, and 4EHP, with ZNF598 failing to co-IP with 4EHP when wild type GIGYF2 was replaced with a 4EHP-binding mutant ([@bib40]). Because all of these proteins can interact with translation complexes, it was unclear whether the observed interactions reflected bridging via mRNA or ribosomes.

We therefore re-investigated potential interactions using cell lysates depleted of ribosomes. We found that FLAG-tagged ZNF598 could co-IP with GIGYF2 ([Figure 5A](#fig5){ref-type="fig"}). This interaction was unaffected by pre-treatment of cells with emetine (which, simply reduced the levels of GIGYF2 in the ribosome-free fraction). Notably, ZNF598 did not co-precipitate EDF1, and GFP-tagged EDF1 did not co-purify either ZNF598 or GIGYF2 ([Figure 5A](#fig5){ref-type="fig"}). Moreover, EDF1 was not necessary for the formation of ZNF598-GIGYF2 complex because the two proteins co-precipitated in EDF1 KO cells ([Figure 5B and C](#fig5){ref-type="fig"}). The lack of a ribosome-free interaction between EDF1 and GIGYF2 was verified with another tag (3xFLAG) ([Figure 5D](#fig5){ref-type="fig"}).

![Analysis of interactions between EDF1, ZNF598, and GIGYF2.\
(**A**) WT HEK293 cells were transfected with constructs encoding indicated proteins (Z- ZNF598-3xFLAG; G - 4EHP-P2A-TST-GIGYF2; E - EDF1-GFP) and allowed to express for 20 hr. Cytosol was depleted of ribosomes by sedimentation and subjected to immunoprecipitation (IP) of 3xFLAG-ZNF598 (left panel) or EDF1-GFP (right panel). When indicated, transfected cells were additionally pre-treated with 1.8 μM emetine for 30 min prior to lysis. Total lysate as well as eluates after IP were analysed by western blotting. The stained blot verifies that the immunoprecipitated proteins were recovered. The IP lanes for each antigen (and the stained blot) are from the same gel and exposure as the lysate lanes, with intervening lanes removed digitally. The relative amounts of lysate and IP samples are indicated on the figure. (**B**) Cells lacking EDF1 (∆EDF1) or GIGYF2 (∆GIGYF2) were transfected with indicated plasmids and analysed as in panel A. (**C**) WT (top panel) or ∆EDF1 (bottom panel) cells were transfected with ZNF598-3xFLAG and 4EHP-P2A-TST-GIGYF2 encoding plasmids. After 20 hr of expression and, when indicated, pre-treatment with 1.8 μM emetine, cell lysates were fractionated on a sucrose gradient. Ribosome free fractions 1--4 and heavy polysome fractions 7--10 were pooled and each was analysed by FLAG-IP and western blotting. (**D**) WT or ∆EDF1 cells were transfected with indicated plasmids and IP was performed as in panel B. Note that EDF1 tagged with 3xFLAG does not recover GIGYF2 (lane 2), unlike ZNF598 containing the same tag (lanes 4 and 6). (**E**) ZNF598-GIGYF2-4EHP form a complex independent of the ribosome. This complex does not include or require EDF1. However, both EDF1 and the ZNF598-GIGYF2-4EHP engage collided ribosomes. Without EDF1, the ZNF598-GIGYF2-4EHP complex is less stably bound to collided ribosomes.](elife-60038-fig5){#fig5}

Thus, ZNF598 interacts with GIGYF2 independently of the ribosome, the latter of which directly interacts with 4EHP. ZNF598 apparently does not interact with 4EHP directly since the two proteins do not co-precipitate in the presence of a GIGYF2 mutant that cannot bind 4EHP ([@bib40]). Although EDF1 is not part of this complex, it co-fractionates with and stabilises (but is not strictly required for) GIGYF2 on collided ribosomes ([Figure 4B](#fig4){ref-type="fig"}). This finding, together with the observation that EDF1 binding to collided ribosomes does not depend on either ZNF598 ([Figure 1](#fig1){ref-type="fig"}) or GIGYF2 ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), suggests a model where EDF1 engages collisions where it helps stabilise the binding of a pre-formed ZNF598-GIGYF2-4EHP complex ([Figure 5E](#fig5){ref-type="fig"}). Although we cannot know the order of binding to the ribosome from these data, we speculate that EDF1 binding may occur first because it is \~50 fold more abundant than either GIGYF2 or ZNF598 ([@bib26]).

The two effectors that are recruited to ribosome collisions impact translation in different ways: GIGYF2 leads to inhibition of initiation, while ZNF598 leads to terminal stalling of elongation. To understand the functional relationship between these two outcomes, we analysed the role of GIGYF2 in ZNF598-mediated ribosome ubiquitination and ribosome stalling. Using cell lines knocked out for either GIGYF2 or EDF1 ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), we found that stall-triggered eS10 ubiquitination was largely unimpaired ([Figure 6A and B](#fig6){ref-type="fig"}), unless ZNF598 was also depleted ([Figure 6C](#fig6){ref-type="fig"}). Thus, ZNF598's ability to selectively recognise and mark collided ribosomes does not depend on EDF1 or GIGYF2.

![ZNF598 and GIGYF2 mediate alternate responses to ribosome collisions.\
(**A**) Total cell lysates from WT and ∆GIGYF2 cells treated with nothing or with collision-inducing low-dose emetine (1.2 µM or 1.8 µM) were analysed by western blotting to monitor ubiquitination of eS10, the primary target of ZNF598. Note that due to its low abundance, the strip of the blot containing ubiquitinated eS10 (Ub-eS10) was detected with higher concentration of primary antibody, but is otherwise from the same membrane and gel used for the other antigens. (**B**) WT and ∆EDF1 cells were treated with nothing, collision-inducing low dose of emetine (1.8 µM) or stall inducing high dose of emetine (360 µM). The lysates were analysed by western blotting to assess ubiquitination of eS10 as in panel A. (**C**) WT and ∆GIGYF2 cells were treated with indicated siRNAs for 72 hr. Where indicated, cells were treated with 1.8 µM emetine for 15 min just prior to lysis. Shown are total cell lysates analysed by western blotting to asses ubiquitination of eS10. Note that in both cell types, eS10 ubiquitination is completely abolished when ZNF598 is knocked down. (**D**) Flp-In T-REx 293 with stably integrated (K^AAA^)~21~ reporter were treated with the indicated siRNAs for 3 days. After an additional 20 hr of doxycycline-induced expression of the fluorescent reporter, the cells were analysed by flow cytometry. Expression of GFP (top panel) and RFP (middle panel) was represented as a histogram for each condition plotted on a log scale. The RFP:GFP ratio (bottom panel) was calculated for each cell line using FlowJo software and also represented as a histogram for each condition.](elife-60038-fig6){#fig6}

This result might initially seem surprising in light of fractionation experiments that showed marked impairment of ZNF598 co-sedimentation with collided ribosomes in cells lacking EDF1 or GIGYF2 ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). On long exposures of the blots, collision-specific co-sedimentation could be seen. This is similar to the finding that GIGYF2 is strongly impaired in binding collisions in cells lacking EDF1 ([Figure 4B](#fig4){ref-type="fig"}). Yet, EDF1 depletion largely phenocopies GIGYF2 loss ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) while ZNF598 ubiquitination of eS10 is unimpaired ([Figure 6A, B and C](#fig6){ref-type="fig"}). This can be rationalised because ubiquitination by ZNF598 only requires a brief interaction (as is typical for ubiquitin ligases and other enzymes) while effective competition for the 5' cap by GIGYF2-4EHP would require its constant presence at collisions. Thus, although EDF1 is needed for stabilisation of both ZNF598 and GIGYF2 at collided ribosomes ([Figure 5E](#fig5){ref-type="fig"}), EDF1 loss preferentially impacts the output from GIGYF2.

Functional analysis of ZNF598 used the dual colour stalling reporter combined with siRNA knockdowns ([Figure 6D](#fig6){ref-type="fig"}). As expected from earlier studies, ZNF598 knockdown results in increased read-through of the (K^AAA^)~21~ stall to generate higher levels of RFP. The slight decrease in GFP, which had previously escaped our attention, might reflect slightly improved GIGYF2 function on collisions lacking ZNF598. With GIGYF2 knockdown, GFP levels increased as expected, but almost no increase in RFP was seen. This indicates a decreased frequency of readthrough, suggesting enhanced ZNF598 function on collisions lacking GIGYF2. The double knockdown showed a combination of the two phenotypes: increased GFP indicating greater translation initiation, and increased RFP indicating greater read-through. Thus, neither ZNF598 nor GIGYF2 depend on the other for function, but each factor's function is slightly enhanced when the other is absent.

Overexpression studies complemented the knockdown experiments and supported these conclusions ([Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}). Overexpression of GIGYF2 together with its binding partner 4EHP resulted in decreased GFP expression indicative of reduced initiation and increased RFP indicative of greater readthrough. The RFP:GFP ratio was therefore substantially elevated, arguing that ZNF598 function in stalling translation was impaired. Conversely, ZNF598 overexpression resulted in increased GFP consistent with impaired GIGYF2 function. While RFP was also increased, the overall RFP:GFP ratio was reduced consistent with enhanced ZNF598 activity. In cells knocked out for either ZNF598 or GIGYF2, overexpression of the other had no appreciable effects. This argues that in these cells, the remaining factor is functioning at maximal capacity so the introduction of additional factor has no consequence. Thus, in wild type cells, ZNF598 partially antagonises the effect of GIGYF2 and vice versa. Inspection of the RFP, GFP, and ratio plots of the flow cytometry experiments from [Figure 4](#fig4){ref-type="fig"} ([Figure 6---figure supplement 4](#fig6s4){ref-type="fig"}) support this conclusion.

Discussion {#s3}
==========

Cells exploit ribosome collision as an indirect indicator of an aberrant mRNA that cannot be successfully translated ([@bib23]; [@bib28]; [@bib63]). Accordingly, the recruitment of ZNF598 to such collisions can initiate mRNA and protein quality control pathways. However, collisions can also indicate the more innocuous situation of high ribosome density caused by overly frequent initiation. Our discovery of a collision-dependent cis-acting mechanism of inhibiting translation initiation suggests that cells monitor ribosome density at a per-mRNA level and dynamically tune initiation rates accordingly. Thus, ribosome collisions emerge as an important parameter that cells use to adjust the quality and quantity of translational output.

At an average density of one ribosome per \~60 codons and a highly variable translation rate that averages \~6 codons per second, collisions are inevitable ([@bib50]; [@bib70]). This is because considerations of optimal resource utilisation dictate that translation efficiency and ribosome density should be at slightly sub-saturation levels ([@bib50]). Consistent with this, electron microscopy images have long shown polysomes contain ribosomes that are typically separated by \~8--15 nm ([@bib42]). In HEK293 cells growing under laboratory conditions, we estimate that \~2--5% of ribosomes are collided at any given moment based on the small but discernible disome peak seen on sucrose gradients after nuclease digestion ([@bib28]). These considerations suggest that a general detector of collisions must be within \~20 fold abundance of ribosomes.

Quantification in Hela cells indicates that EDF1 is present in \~1 million copies per cell ([@bib33]), roughly one-fourth to one-sixth the concentration of ribosomes as measured in the same study. By contrast, GIGYF2 and ZNF598 are estimated to be around 50-fold lower ([@bib26]), although this may vary by cell type. We therefore posit that EDF1 is a general collision sensor that arrives first at any collision due to its very high abundance. If the collision is simply due to stochastic variations in ribosome spacing along an mRNA, elongation would continue, the ribosome spacing would quickly change, and EDF1 would dissociate without any action being taken. Because each round of elongation only takes \~200 milliseconds \[i.e., an average of \~5 amino acids per second ([@bib66])\], these events would all be complete within a second or so.

If the collision is due to a genuine slowdown, EDF1 would be retained on collided ribosomes for longer, thereby stabilising the ZNF598-GIGYF2-4EHP complex at the collision ([Figure 7](#fig7){ref-type="fig"}). While GIGYF2 co-fractionation with collided ribosomes is diminished without EDF1, it is not lost entirely. Similarly, ZNF598 binding to collided ribosomes is substantially less stable but not eliminated in the absence of either EDF1 or GIGYF2. In each case, the ribosome interaction is collision-specific. This is consistent with a model in which the disome-EDF1 complex provides an optimal platform for ZNF598-GIGYF2-4EHP binding. This could occur in one of two ways: (i) a direct model where EDF1 provides part of a binding site for the ZNF598-GIGYF2-4EHP complex on collided ribosomes; (ii) an indirect model where EDF1 engagement of collided ribosomes changes the ribosome complex in a way that favours the bound state of the ZNF598-GIGYF2-4EHP complex. Future structural analysis of the complex engaged on a collided disome is required to address these details.

![Model for tiered response to ribosome collisions.\
When two ribosomes collide, EDF1 is most likely to engage the collision first due to its high abundance. Because downstream responses require recruitment of additional factors, no action is taken if the collision resolves quickly by elongation of the lead ribosome. This allows for random bumping of ribosomes on a crowded message. However, if resolution is not immediate, EDF1 stabilises the ZNF598-GIGYF2-4EHP complex. 4EHP inhibits initiation via sequestration of the 5' cap to avoid further increase in ribosome density. This inhibition is relieved in one of two ways. If the collision is incidental (left limb), as might occur at sites of physiologic ribosome pausing, elongation resumes through the action of eEF1A in complex with aminoacyl-tRNA (aa-tRNA). If the collision is persistent (right limb), as would occur at sites of pathologic stalling, ZNF598 ubiquitinates the ribosome, which signals the ASC-1 complex (ASCC) to disassemble the lead ribosome. The 60S complex of the disassembled lead ribosome engages the ribosome quality control (RQC) complex. Because the stalled ribosome and ensuing collision has been resolved, elongation of trailing ribosomes resumes, causing dissociation of EDF1 and the ZNF598-GIGYF2-4EHP complex. Loss of 4EHP permits initiation to resume. Ub is ubiquitin.](elife-60038-fig7){#fig7}

Once recruited, GIGYF2 can repress translation initiation. As established previously, GIGYF2 forms a complex with 4EHP ([@bib40]), which competes with the translation factor eIF4E for the 5' cap ([@bib11]). 4EHP is ordinarily not able to outcompete eIF4E ([@bib76]) unless its local concentration in the vicinity of an mRNA is high. Such a model would explain how collisions can selectively inhibit translation initiation of the mRNA on which the collision occurred. Consistent with this idea, artificially recruiting the GIGYF2-4EHP complex to an mRNA is sufficient to inhibit translation initiation in cis ([@bib22]).

Because incidental collisions may be a pervasive feature across the transcriptome ([@bib1]; [@bib19]), the GIGYF2-4EHP axis is expected to impact the translation of a wide range of mRNAs. Earlier experiments in cells lacking GIGYF2 or 4EHP showed \~30% higher rates of translation globally ([@bib40]). Strikingly, the native size of polysomes in 4EHP knockout tissue was increased by the size of 1--2 ribosomes, indicating that ribosome density on mRNAs is increased across the transcriptome.

Reduction of initiation rates via the GIGYF2-4EHP axis provides time for resolution of the collision without incurring further collisions. Resolution can occur in one of two ways. If the collision is incidental due to a physiologic pause in translation, elongation would soon resume, at which point EDF1 and the ZNF598-GIGYF2-4EHP complex would dissociate to allow initiation to begin again ([Figure 7](#fig7){ref-type="fig"}, left). Given the abundance and speed of elongation factor action, resumption of translation would typically occur in under a second. The broadest estimates of normal elongation rates span at most a \~20 fold range ([@bib52]; [@bib66]). Thus, even in particularly unusual instances where a ribosome lingered for 20-fold longer than a normal elongation cycle, it would still re-start in \~4 s.

The longer a collision persists, the greater the likelihood that ZNF598 will ubiquitinate 40S proteins including eS10 ([Figure 7](#fig7){ref-type="fig"}, right). Depending on the ligase and other parameters, ubiquitination reactions can occur on the timescale of milliseconds to minutes ([@bib45]; [@bib38]). A time course of ZNF598 ubiquitination of ribosomes in vitro at close to physiologic concentrations indicate that it takes at least \~2--5 min to accumulate appreciable 40S ubiquitination ([@bib30]). Because there are likely to be deubiquitinase(s) that can act on the ribosome ([@bib14]), 40S ubiquitination is not the commitment step to trigger RQC. Instead, ubiquitinated eS10 is needed for the ASC-1 complex (ASCC) to act ([@bib29]; [@bib37]).

ASCC is a conserved complex containing the ASCC3 helicase (Slh1 in yeast) involved in resolving collided ribosomes ([@bib13]; [@bib21]; [@bib23]; [@bib29]; [@bib36]; [@bib37]). Recent experiments suggest that by directly dissociating the lead ribosome into subunits, ASCC is the factor that irreversibly aborts translation and initiates RQC on the stalled ribosome ([@bib29]; [@bib37]). Having resolved the troublesome ribosome, the downstream ribosomes are then free to elongate ([@bib29]).

Because the commitment to RQC is two steps removed from ZNF598 recruitment and involves the trans-acting ASCC, this limb of the response is likely to take between one to many minutes. By contrast, the simple binding reaction represented by 4EHP interacting with the 5' cap in cis would occur at millisecond to low-second time scales given the constrained local concentrations of the interaction partners. Although we have not made all of these measurements, their estimates are based on well-established biochemical principles. Thus, we propose that collisions initiate a tiered response that begins with the conservative strategy of inhibiting initiation (the 1° response) followed later by the destructive strategy of initiating quality control (the 2° response). If the lead ribosome elongates at any point prior to ASCC action, the distinctive architecture of the collided disome would be lost, causing dissociation of the EDF1 and the ZNF598-GIGYF2-4EHP complex.

Even though ZNF598 is more stable on collisions containing EDF1 and GIGYF2, ZNF598-mediated eS10 ubiquitination does not require either protein. Hence, RQC can be effectively triggered without EDF1 or GIGYF2. Similarly, GIGYF2 does not require ZNF598 for either its stability on collisions or its effect on translation initiation. While future structural studies are needed to understand the physical relationship of these factors on the collided ribosome, our biochemical and functional analyses suggest that they do not compete for a common site.

Nevertheless, GIGYF2 and ZNF598 do functionally compete for the outcome downstream of ribosome collisions. This can be rationalised because each pathway reduces collisions needed by the other pathway's output. The ZNF598 limb reduces collisions by ultimately splitting the lead ribosome. Thus, increased output through this limb means fewer collided ribosomes from which the GIGYF2-4EHP complex can inhibit initiation. On the other hand, increased output through the GIGYF2-4EHP limb reduces the initiation rate, reducing collisions on which ZNF598 can act.

The implication of this tiered model is that the ratio of GIGYF2 to ZNF598 effectively sets the persistence threshold at which collisions trigger quality control. This key ratio may vary across cell types as evidenced by the lack of ZNF598 in reticulocytes ([@bib28]; [@bib39]) and its particularly high expression in oocytes ([@bib17]; [www.genevisible.com](http://www.genevisible.com)). Reticulocytes may forego quality control in order to translate at maximal levels, while other cell types might show particularly sensitive quality control to minimise aberrant proteins. The regulatory aspect of how cells respond to collisions remains to be explored.

Although relatively little was previously known about EDF1, the yeast homolog Mbf1 was identified in a screen for genes that suppress frameshifting at ribosome stalling sequences ([@bib71]). Given the recent finding that suggests ribosome collisions can cause frameshifting ([@bib64]), our results provide a plausible explanation for the increased frameshifting observed in ∆Mbf1 yeast strains. By removing a factor that helps to suppress initiation in response to collisions, the collision rate would increase, resulting in increased frameshifting. Consistent with this idea, yeast has two GIGYF2 homologs (Smy2 and Syh1) whose overexpression suppresses translation of a stall-containing reporter ([@bib13]). Although yeast does not have an obvious 4EHP homolog, Smy2 interacts with Eap1, an inhibitor of eIF4E function ([@bib55]). Thus, it is likely that the cis-acting collision-mediated feedback loop described in our study is widely conserved.

If each collision is accompanied by a slight increase in the probability of frameshifting, minimising their occurrence would be important for avoiding the production of aberrant proteins. Whether the accumulation of aberrant frameshifted proteins is the basis for the neurodegenerative-like phenotype of partial GIGYF2 deficiency ([@bib16]) remains to be explored. It is particularly intriguing that this phenotype resembles in some ways the partial deficiency of Listerin ([@bib12]), which acts downstream of ZNF598 ([@bib15]; [@bib30]; [@bib67]). Thus, by acting to minimise (via the GIGYF2 limb) and resolve (via the ZNF598 limb) ribosome collisions, both pathways seem to protect the proteome from detrimental translation products that may contribute to neurodegenerative disease.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                  Designation                                         Source or reference        Identifiers                                                                         Additional\
  (species) or resource                                                                                                                                                                             information
  ------------------------------ --------------------------------------------------- -------------------------- ----------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------
  Cell line\                     HEK293T                                             ATCC                       CRL-3216; RRID:[CVCL_0063](https://scicrunch.org/resolver/CVCL_0063)                
  (*H. sapiens*)                                                                                                                                                                                    

  Cell line (*H. sapiens*)       Flp-In T-REx 293                                    Thermo Fisher              R78007;\                                                                            
                                                                                                                RRID:[CVCL_U427](https://scicrunch.org/resolver/CVCL_U427)                          

  Cell line (*H. sapiens*)       Flp-In T-REx 293 GFP-P2A-(KAAA)21-P2A-RFP           [@bib30]                                                                                                       

  Cell line (*H. sapiens*)       Flp-In T-REx 293 TRex GFP-P2A-(K)0-P2A-RFP          [@bib30]                                                                                                       

  Cell line (*H. sapiens*)       Flp-In T-REx 293 GFP-P2A-(KAAA)21-P2A-RFP ∆ZNF598   [@bib30]                                                                                                       

  Cell line (*H. sapiens*)       Flp-In T-REx 293 GFP-P2A-(KAAA)21-P2A-RFP ∆GIGYF2   This paper                                                                                                     CRISPR/Cas9 targeting GIGYF2, clonal selection

  Cell line (*H. sapiens*)       Flp-In T-REx 293 GFP-P2A-(KAAA)21-P2A-RFP ∆EDF1     This paper                                                                                                     CRISPR/Cas9 targeting EDF1, clonal selection

  Antibody                       anti-ZNF598 (rabbit polyclonal)                     Abcam                      Cat \#ab80458; RRID:[AB_2221273](https://scicrunch.org/resolver/AB_2221273)         WB (1:500)

  Antibody                       anti-uL2 (rabbit polyclonal)                        Abcam                      Cat \#ab169538; RRID:[AB_2714187](https://scicrunch.org/resolver/AB_2714187)        WB (1:10000)

  Antibody                       anti-eS24 (rabbit polyclonal)                       Abcam                      Cat \#ab196652; RRID:[AB_2714188](https://scicrunch.org/resolver/AB_2714188)        WB (1:2500)

  Antibody                       HRP-conjugated anti-FLAG (mouse monoclonal)         Sigma                      cat \#A8592; RRID:[AB_439702](https://scicrunch.org/resolver/AB_439702)             WB (1:5000)

  Antibody                       anti-eS10 (rabbit monoclonal)                       Abcam                      cat \#ab151550; RRID:[AB_2714147](https://scicrunch.org/resolver/AB_2714147)        WB (1:5000 -- unmodified eS10; 1:250 -- Ub-eS10)

  Antibody                       HRP-conjugated anti-beta-Actin (mouse monoclonal)   Sigma                      cat \#A3854; RRID:[AB_262011](https://scicrunch.org/resolver/AB_262011)             WB (1:10000)

  Antibody                       anti-GIGYF2 (rabbit polyclonal)                     Bethyl                     cat \#A303-732A; RRID:[AB_11205815](https://scicrunch.org/resolver/AB_11205815)     WB (1:2000)

  Antibody                       anti-EDF1 (rabbit polyclonal)                       Bethyl                     cat \#A304-039A; RRID:[AB_2621288](https://scicrunch.org/resolver/AB_2621288)       WB (1:1000)

  Antibody                       anti-RACK1 (rabbit polyclonal)                      Bethyl                     cat \#A302-545A; RRID:[AB_1999012](https://scicrunch.org/resolver/AB_1999012)       WB (1:2000)

  Antibody                       anti-4EHP (rabbit polyclonal)                       GeneTex                    cat \#GTX103977; RRID:[AB_2036842](https://scicrunch.org/resolver/AB_2036842)       WB (1:250)

  Antibody                       anti-GFP (rabbit polyclonal)                        [@bib8]                                                                                                        WB (1:5000)

  Antibody                       HRP-conjugated anti-mouse (goat polyclonal)         Jackson ImmunoResearch     cat \#115-035-003; RRID:[AB_10015289](https://scicrunch.org/resolver/AB_10015289)   WB (1:5000)

  Antibody                       HRP-conjugated anti-rabbit (goat polyclonal)        Jackson ImmunoResearch     cat\# 111-035-003; RRID:[AB_2313567](https://scicrunch.org/resolver/AB_2313567)     WB (1:5000)

  Recombinant DNA reagent        pX459-EDF1- sgRNA1                                  This paper                                                                                                     sgRNA targeting EDF1

  Recombinant DNA reagent        pX459-EDF1- sgRNA2                                  This paper                                                                                                     sgRNA targeting EDF1

  Recombinant DNA reagent        pX459-GIGYF2- sgRNA1                                This paper                                                                                                     sgRNA targeting GIGYF2

  Recombinant DNA reagent        pX459-GIGYF2- sgRNA2                                This paper                                                                                                     sgRNA targeting GIGYF2

  Recombinant DNA reagent        pcDNA3.1-ZNF598-TEV-3xFLAG                          [@bib30]                   RRID:[Addgene_105690](https://scicrunch.org/resolver/Addgene_105690)                Human ZNF598 with TEV-3xFLAG tag at the C-terminus for mammalian expression

  Recombinant DNA reagent        pcDNA3.1-EDF1-TEV-3xFLAG                            This paper                                                                                                     Human EDF1 tagged with TEV-3xFLAG at the C-terminus for mammalian expression

  Recombinant DNA reagent        pcDNA3.1-EDF1-GFP                                   This paper                                                                                                     Human EDF1 tagged with GFP at the C-terminus for mammalian expression

  Recombinant DNA reagent        pCMV-4EHP-HA                                        This paper                                                                                                     Human 4EHP tagged with HA at the C-terminus for mammalian expression

  Recombinant DNA reagent        pcDNA3.1-4EHP-P2A-Twin-Strep-GIGYF2                 This paper                                                                                                     Human 4EHP and Twin-Strep tagged GIGYF2 for mammalian expression

  Recombinant DNA reagent        pcDNA3.1-EDF1(R85G)-TEV-3xFLAG                      This paper                                                                                                     Human EDF1 R85G mutant tagged with TEV-3xFLAG at the C-terminus for mammalian expression

  Recombinant DNA reagent        pSP64-EDF1-TST                                      This paper                                                                                                     Human EDF1 tagged with C-terminal TST for in vitro\
                                                                                                                                                                                                    transcription and translation

  Recombinant DNA reagent        pSP64-EDF1(R85G)-TST                                This paper                                                                                                     Human EDF1 R85G mutant with C-terminal TST for in vitro transcription and translation

  Recombinant DNA reagent        pCMV-GFP-P2A-3XFLAG-VHPb-K(AAA)12+0-RFP             [@bib30]                                                                                                       Frameshifting reporters based on K12 poly sequence

  Recombinant DNA reagent        pCMV-GFP-P2A-3XFLAG-VHPb-K(AAA)12+1-RFP             [@bib30]                                                                                                       Frameshifting reporters based on K12 poly sequence

  Recombinant DNA reagent        pCMV-GFP-P2A-3XFLAG-VHPb-K(AAA)12--1-RFP            [@bib30]                                                                                                       Frameshifting reporters based on K12 poly sequence

  Recombinant DNA reagent        pCMV-GFP-P2A-3XFLAG-VHPb-WT_XBP1_4AAA+0-RFP         This paper                                                                                                     Frameshifting reporterts based on XBP1 stalling sequence

  Recombinant DNA reagent        pCMV-GFP-P2A-3XFLAG-VHPb-S255A_XBP1_4AAA+0-RFP      This paper                                                                                                     Frameshifting reporterts based on XBP1 stalling sequence

  Recombinant DNA reagent        pCMV-GFP-P2A-3XFLAG-VHPb-W256A_XBP1_4AAA+0-RFP      This paper                                                                                                     Frameshifting reporterts based on XBP1 stalling sequence

  Recombinant DNA reagent        pCMV-GFP-P2A-3XFLAG-VHPb-WT_XBP1_4AAA+1-RFP         This paper                                                                                                     Frameshifting reporterts based on XBP1 stalling sequence

  Recombinant DNA reagent        pCMV-GFP-P2A-3XFLAG-VHPb-S255A_XBP1_4AAA+1-RFP      This paper                                                                                                     Frameshifting reporterts based on XBP1 stalling sequence

  Recombinant DNA reagent        pCMV-GFP-P2A-3XFLAG-VHPb-W256A_XBP1_4AAA+1-RFP      This paper                                                                                                     Frameshifting reporterts based on XBP1 stalling sequence

  Recombinant DNA reagent        pCMV-GFP-P2A-3XFLAG-VHPb-WT_XBP1_4AAA-1-RFP         This paper                                                                                                     Frameshifting reporterts based on XBP1 stalling sequence

  Recombinant DNA reagent        pCMV-GFP-P2A-3XFLAG-VHPb-S255A_XBP1_4AAA-1-RFP      This paper                                                                                                     Frameshifting reporterts based on XBP1 stalling sequence

  Recombinant DNA reagent        GFP-P2A-3XFLAG-VHPb-W256A_XBP1_4AAA-1-RFP           This paper                                                                                                     Frameshifting reporterts based on XBP1 stalling sequence

  Recombinant DNA reagent        pRSETA 6xHIS-TEV-eRF1(AAQ)                          [@bib7]                                                                                                        Human mutant eRF1(AAQ)\
                                                                                                                                                                                                    for expression in *E. coli*

  Sequence-based reagent         CRISPR: EDF1 sgRNA1                                 IDT                                                                                                            5\' - ATCTTAGCGGCACAGAGACG - 3\'

  Sequence-based reagent         CRISPR: EDF1 sgRNA1                                 IDT                                                                                                            5\' - GAGCAAGGGGCTTACGCAGA - 3\'

  Sequence-based reagent         CRISPR: GIGYF2 sgRNA1                               IDT                                                                                                            5\' - GGGAACACATGGAACGACGT - 3\'

  Sequence-based reagent         CRISPR: GIGYF2 sgRNA2                               IDT                                                                                                            5\' - GGCGACTAGCTGGATCAAGG - 3\'

  Sequence-based reagent         siRNA: control                                      Thermo Fisher              4390843                                                                             Silencer Select

  Sequence-based reagent         siRNA: EDF1 \#1                                     Thermo Fisher              \#16610                                                                             Silencer Select

  Sequence-based reagent         siRNA: EDF1 \#2                                     Thermo Fisher              \#s225027                                                                           Silencer Select

  Sequence-based reagent         siRNA: GIGYF2 \#1                                   Thermo Fisher              \#s25033                                                                            Silencer Select

  Sequence-based reagent         siRNA: GIGYF2 \#2                                   Thermo Fisher              \#s25034                                                                            Silencer Select

  Sequence-based reagent         siRNA: ZNF598                                       Thermo Fisher              \#s40509                                                                            Silencer Select

  Sequence-based reagent         siRNA: 4EHP                                         Thermo Fisher              \#s18149                                                                            Silencer Select

  Sequence-based reagent         siRNA: 4EHP                                         Thermo Fisher              \#s18150                                                                            Silencer Select

  Sequence-based reagent         GAPDH Forward primer for RT-PCR                     IDT                                                                                                            5'-AGCTCATTTCCTGGTATGACA-3'

  Sequence-based reagent         GAPDH Reverse primer for RT-PCR                     IDT                                                                                                            5'-AGGGGAGATTCAGTGTGGTG-3'

  Sequence-based reagent         RPLP1 Forward primer for RT-PCR                     IDT                                                                                                            5'-CTCACTTCATCCGGCGACTAG-3'

  Sequence-based reagent         RPLP1 Reverse primer for RT-PCR                     IDT                                                                                                            5'-GCAGAATGAGGGCCGAGTAG-3'

  Sequence-based reagent         GFP Forward primer for RT-PCR                       IDT                                                                                                            5'-GGCAAGCTGACCCTGAAGTT-3'

  Sequence-based reagent         GFP Reverse primer for RT-PCR                       IDT                                                                                                            5'-CTTGTAGTTGCCGTCGTCCT-3'

  Sequence-based reagent         RFP Forward primer for RT-PCR                       IDT                                                                                                            5'-AGCAAGGGCGAGGAGGATAA-3'

  Sequence-based reagent         RFP Reverse primer for RT-PCR                       IDT                                                                                                            5'- TAGGCCTTGGAGCCGTACAT-3'

  Peptide, recombinant protein   S7 Micrococcal Nuclease                             Roche                      Cat \#11873580001                                                                   purified protein

  Chemical compound, drug        Hygromycin B                                        Millipore                  Cat \#400051-100KU                                                                  Selection antibiotic

  Chemical compound, drug        Blasticidin S                                       Santa Cruz Biotechnology   Cat \#sc204655                                                                      Selection antibiotic

  Chemical compound, drug        Emetine                                             Calbiochem                 Cat \#324693                                                                        Used to induce ribosomal stalling

  Software, algorithm            FlowJo                                              FlowJo                     RRID:[SCR_008520](https://scicrunch.org/resolver/SCR_008520)                        Analysis of FACS data

  Software,\                     GraphPad Prism                                      GraphPad Prism             RRID:[SCR_008520](https://scicrunch.org/resolver/SCR_008520)                        Statistical analysis,\
  algorithm                                                                                                                                                                                         graphs

  Other                          Complete EDTA-free protease inhibitor cocktail      Roche                      Cat \#118735800001                                                                  
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Plasmids {#s4-1}
--------

The expression plasmid for 3xFLAG-tagged ZNF598 (pcDNA3.1-ZNF598-TEV-3xFLAG) was previously described ([@bib30]) and is available at Addgene (\#105690). The EDF1 expression plasmid (pcDNA3.1-EDF1-TEV-3xFLAG) was prepared the same way using the EDF1 ORF amplified from cDNA prepared from HEK293 cells. The R85G mutant of EDF1 was generated by site-directed mutagenesis. The EDF1-GFP plasmid was generated using Gibson assembly-based cloning with pcDNA3.1-EDF1-TEV-3xFLAG as a template and PCR amplified GFP-encoding sequence. The plasmid for co-expression of 4EHP and GIGYF2 was assembled in pcDNA3.1 as follows. First, a pcDNA3.1-based plasmid containing Twin-Strep-GIGYF2 was prepared, after which the 4EHP ORF \[PCR amplified from a commercially available plasmid (Origene cat. RC201391)\] was inserted 5' of a P2A sequence that preceded GIGYF2. Plasmids for in vitro transcription and translation of EDF1 were pSP64-based. EDF1 WT or R85G mutant ORF sequences were amplified from pcDNA-based plasmids and inserted 5' of the Twin-Strep tag (TST) resulting in pSP64-EDF1-TST and pSP64-EDF1(R85G)-TST plasmids. Previously described plasmid pRSETA-6xHIS-TEV-eRF1^AAQ^ was used for recombinant expression of eRF1^AAQ^ in *E. coli *([@bib7]). Plasmids for CRISPR-Cas9 gene disruption used px459 plasmid as a backbone ([@bib48]), Addgene plasmid \#62988), with sgRNA sequences that are provided in the Key resources table. Reporter constructs for frameshifting analysis at (K^AAA^)~12~ sequences were previously described ([@bib30]). Frameshifting reporters encoding WT, S255A and W256A XBP1 mutants were generated by standard restriction digestion and ligation of chemically synthesised oligonucleotides using (K^AAA^)~12~ +0, +1,--1 frameshifting reporters as backbones.

Cell lines {#s4-2}
----------

This work employed Flp-In T-REx 293 cells (from Thermo Fisher Scientific) and several stable cell lines derived from it. All cells are checked approximately monthly for mycoplasma contamination and verified to be negative. The identity of the founding cell line is verified by the presence of the FRT locus and accompanying antibiotic resistance. The derived cell lines are verified by antibiotic resistance and the reporters they express.

WT and ∆ZNF598 Flp-In T-REx 293 cells with stably integrated, doxycycline-inducible reporters (K^AAA^)~21~ and (K)~0~ were previously described ([@bib30]). ∆EDF1 and ∆GIGYF2 cells were generated using CRISPR-Cas9 methodology in Flp-In T-REx 293 cells already containing the (K^AAA^)~21~ reporter. Briefly, the cells were transiently transfected with px459 plasmid encoding sgRNA sequences (see Key resources table). 24 hr post transfection, cells were transferred to media containing 1 µg/ml of puromycin to select the cells positively transfected with the plasmid. 72 hr post transfection, positively selected cells were trypsinised and subcloned into 96-well plates at a density close to 0.5 cell/well to obtain single cell clones. Colonies were allowed to grow for \~2 weeks. Individual clones were expanded and screened for the expression of protein using western blotting of the total cell lysates. Multiple clones (at least 3) showing no detectable expression of the protein of interest were selected for further validation using phenotypic screening by flow cytometry.

Cell cultures {#s4-3}
-------------

All cells were maintained in Dulbecco's Modified Eagles's Medium (DMEM) with 10% of tetracycline-free fetal calf serum (FCS). In case of Flp-In T-REx 293 cells harbouring doxycycline inducible reporters, 15 µg/ml blasticidin and 100 µg/ml hygromycin were included in the media. Induction of the reporter expression was with 1 µg/ml of doxycycline for the times indicated in the figure legends. Treatment with emetine was for 1 hr with the following concentrations: high -- 360 µM or low 1.8 µM unless otherwise indicated in the individual figure legends. Transfections with plasmid DNA were performed with TransIT-293 (Mirus) according to manufacturer's protocol. Silencing with siRNAs was typically for 72 hr (unless otherwise stated in the figure legends), using Lipofectamine RNAiMAX (Thermo Fisher). When longer silencing was needed, the cells were split and transfected again with fresh siRNA after the first 72 hr.

Flow cytometry analysis {#s4-4}
-----------------------

Analysis of the dual-fluorescent reporter using flow cytometry was as described previously ([@bib30]). Briefly, cells cultured on 24-well plates, induced with doxycycline for the times indicated in the figure legends, were washed with PBS, trypsinised, collected in DMEM containing 10% FCS, and spun for 3 min at 5000 rpm using a tabletop centrifuge. Cell pellets were resuspended in 500 µl of ice-cold PBS, filtered through a 70 µm cell strainer, and analysed using the Becton Dickinson LSRII instrument. 20,000--30,000 GFP-positive events were collected for each sample. Data analysis used FlowJo software. For the analysis of frameshifting, Flp-In T-REx 293 cells cells were first transfected with siRNAs targeting EDF1 or non-targeting siRNAs as a negative control. After \~72 hr continued culture, cells were washed with PBS, trypsinised, and seeded again at lower density. Three parallel dishes were then each transfected with one of the three frameshifting constructs together with a BFP-encoding plasmid at a ratio of 1:1. Expression of the frameshifting reporters was allowed for \~20 hr before preparing the cells for flow cytometry analysis as described above. Data were collected on 20,000--30,000 BFP-positive cells (as a marker for transfection), with BFP-negative cells serving as a negative control to judge the level of background autofluorescence in each channel. To calculate the amount of frameshifting observed in +1 and −1 frames, median fluorescence intensity (hereafter MFI) of the RFP signal was derived using FlowJo software. The background RFP MFI derived from non-transfected cells was first subtracted from MFI values obtained for all the constructs, and the amount of signal in +1 and −1 frames was calculated as a percentage of the RFP MFI in +0 frame. GFP levels were verified to be equal among the three constructs as an indicator of equal expression.

Immunoprecipitation experiments {#s4-5}
-------------------------------

The cell lines indicated in the figure legend were transfected with the constructs indicated in the figure legend. A single 10 cm dish was used for each experimental condition. Expression of transgenes was allowed for \~20 hr and where indicated in the figure, cells were additionally treated with 1.8 μM emetine for 30 min immediately prior to cell lysis. Each plate was washed with ice cold PBS twice, cells were collected in ice cold PBS by scraping, and spun for 3 min at 5,000 rpm using a tabletop centrifuge chilled to 4°C. For the experiments in [Figure 5A, B and D](#fig5){ref-type="fig"}, lysis was performed for 15 min on ice using 400 μl of 1xRNC buffer supplemented with 0.5% Triton X-100 and 1 mM DTT. The nuclei and cell debris were spun for 10 min at 15,000 g using a tabletop centrifuge at 4°C. The post-nuclear supernatant was further spun for 1 hr at 100,000 rpm at 4°C using a TLA120.2 rotor to obtain ribosome-free cytosolic extracts. FLAG-M2 resin or GFP-trap agarose resin were added directly to the ribosome-free supernatants and incubated for 1 hr at 4°C with end-over-end rolling. Beads were washed with the lysis buffer four times and elution was performed for 5 min at 95°C using SDS-sample buffer (in case of the GFP trap resin) or for 45 min at room temperature with shaking using 0.2 mg/ml FLAG peptide in 1xRNC. For the experiment in [Figure 5C](#fig5){ref-type="fig"}, cells were lysed for 15 min on ice using 200 μl of 1xRNC supplemented with 0.05% digitonin and 1 mM DTT. Cell rupture was ensured by passing the lysates through 26G needle appended to 1 ml syringe. The lysates were spun for 10 min at 15,000 g and supernatants were loaded on 2 ml of pre-equilibrated 10--50% sucrose gradients. The gradients were centrifuged at 55,000 rpm for 1 hr at 4°C using the TLS-55 rotor and slowest acceleration and deceleration settings. 11 fractions, 200 μl each were collected manually from the top of the gradient and fractions 1--4 (non-ribosomal fractions), and fractions 7--10 (heavy polysomal fractions) were pooled together. Digitonin was added to each of the pooled fractions to achieve 0.05% final concentration and the IP was performed for 1 hr in the cold room with end-over-end rolling using anti-FLAG M2 affinity resin. The resin was washed four times with the lysis buffer and elution was performed as described above using 0.2 mg/ml FLAG peptide in 1xRNC buffer.

Quantitative mass spectrometry of purified polysomes {#s4-6}
----------------------------------------------------

HEK293 cells were grown on 10 cm plates. One 10 cm plate was used for each experimental condition, which was performed in duplicate. 90% confluent cells were treated for 15 min with a low dose of emetine (1.8 µM), a high dose of emetine (360 µM) or with DMSO (control). Prior to harvesting, cells were washed with ice cold PBS twice. Lysis was in 200 µl for 20 min on ice using 1xRNC buffer \[50 mM HEPES pH 7.6, 100 mM K(OAc), 5 mM Mg(OAc)~2~\] supplemented with 0.01% purified digitonin, 40 U/ml RNAsin, 1x protease inhibitor cocktail, and 1 mM DTT. Cells were ruptured by passing through a 26G needle using a 1 ml syringe (20 passes). Lysates were sedimented by centrifugation for 15 min at 15,000 g at 4°C using a tabletop centrifuge. The resulting supernatant was loaded onto a 10--50% sucrose gradient (2 ml gradient volume) in 1xRNC buffer. Centrifugation was for 1 hr at 55,000 rpm in the TLS 55 rotor (Beckman) at 4°C using the slowest acceleration and deceleration settings. After the spin, 11 fractions were manually collected from the top of the gradient. Fractions 8--11 were pooled together (previously verified to represent polysomal fractions), diluted with an equal volume of 1xRNC buffer (800 μl) and centrifuged for 1 hr at 100,000 rpm in the TLA100.3 rotor at 4°C. The polysome pellet was washed once with 200 μl of 1xRNC and resuspended in 20--50 μl of 1xRNC buffer. The concentrations of samples were normalised using absorbance at 260 nm and subjected to quantitative mass spectrometry using Tandem Mass Tagging (TMT) approach ([@bib68]). In brief, quantitative mass spectrometry was performed by in-solution digestion of samples, followed by tandem mass tag labelling (Thermo Fisher Scientific cat. \#90110). Protein samples in solution were reduced with 5 mM DTT at 56°C for 30 min and alkylated with 10 mM iodoacetamide for 30 min in the dark at 22°C. The alkylation reaction was quenched by the addition of DTT and the samples were digested with trypsin (Promega, 0.5 μg) overnight at 37°C. The peptide mixtures were then desalted using home-made C18 (3M Empore) stage tip filled with 0.5 mg of poros R3 (Applied Biosystems) resin. Bound peptides were eluted sequentially with 30%, 50% and 80% acetonitrile in 0.1%TFA and lyophilised. Dried peptide mixtures from each condition were resuspended in 20 μL of 7% acetonitrile, 200 mM triethyl ammonium bicarbonate. For TMT labelling, 0.8 mg of TMT reagents (Thermo Fisher Scientific) were reconstituted in 41 μL anhydrous acetonitrile. 10 μL of TMT was added to each peptide mixture and incubated for 1 hr at room temperature. The labelling reactions were terminated by incubation with 2.5 μL 5% hydroxylamine for 15 min, and labelled samples were subsequently pooled. The acetonitrile was evaporated using a Speed Vac, desalted and then fractionated with home-made C18 (3M Empore) stage tip using 10 mM ammonium bicarbonate and acetonitrile gradients. Eluted fractions were partially dried down using a Speed Vac and subjected to LC-MSMS. Liquid chromatography was performed on a fully automated Ultimate 3000 RSLC nano System (Thermo Scientific) fitted with a 100 µm × 2 cm PepMap100 C18 nano trap column and a 75 μm × 25 cm reverse phase C18 nano column (Aclaim PepMap, Thermo Scientific). Samples were separated using a binary gradient consisting of buffer A (2% acetonitrile, 0.1% formic acid) and buffer B (80% acetonitrile, 0.1% formic acid). Peptides were eluted at 300 nL/min with an acetonitrile gradient. The HPLC system was coupled to a Q Exactive Plus hybrid quardrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific) equipped with a nanospray ion source. The acquired MSMS raw files were processed using Proteome Discoverer (version 2.1, Thermo Scientific). MSMS spectra were searched against mammals, UniProt Fasta database using Mascot (version 2.4, Matrix Science) search engine.

Analytical sucrose gradient fractionations {#s4-7}
------------------------------------------

Small scale, analytical sucrose gradient fractionations were as described previously ([@bib30]). Briefly, 20 μl of sample was loaded on 200 μl of 10--50% sucrose gradient prepared by overlaying 40 µl layers of 50%, 40%, 30%, 20% and 10% sucrose solutions dissolved in 1xRNC buffer. Gradients were allowed to equilibrate for 1 hr prior to centrifugation. Spin was for 20 min, at 4°C, at 55,000 rpm using slowest acceleration and deceleration settings in TLS-55 rotor (Beckman). Eleven consecutive fractions, 20 μl each, were collected manually from the top of the gradient and analysed directly.

Analysis of cell lysates using sucrose gradient fractionation {#s4-8}
-------------------------------------------------------------

Cells at \~80% confluency, grown on 10 cm plates (two plates per sample) were either treated with low dose (1.8 μM) of emetine or DMSO control for 1 hr. Before harvesting by scraping, cells were moved on ice and washed twice with ice cold PBS. Harvested cells were spun at 4°C at 1000 rpm for 5 min and resuspended in 100--200 μl of 1xRNC buffer containing 0.01% purified digitonin, 40 U/ml RNAsin inhibitor (Promega), 1 mM DTT, and 1x EDTA-free protease inhibitors cocktail. After 15 min incubation on ice, cells were ruptured by passing through pre-chilled 21G needle attached to 1 ml syringe \~15 times. Cell debris was removed by 10 min spin at 15,000 g at 4°C using a tabletop microcentrifuge. The protein concentrations of post-spin supernatants were measured using nanodrop. 150 μg of protein in the lysate was adjusted to 20 μl volume using lysis buffer, loaded on 10--50% analytical sucrose gradient and analysed as described above.

Western blotting {#s4-9}
----------------

Western blotting was performed as described previously ([@bib30]). For the analysis of cell-derived samples, cells were washed twice with ice cold PBS and harvested. After short spin (3 min at 5000 rpm) in microcentrifuge, cell pellets were lysed using 100 mM Tris pH 8.0 with 1% SDS. To shear genomic DNA, lysates were boiled at 95°C and vortexed extensively. Samples were analysed using Tris-Tricine SDS-PAGE electrophoresis followed by wet transfer to 0.2 μm nitrocellulose membrane. Blocking was for 1 hr at room temperature and incubation with primary antibodies was for 1 hr at room temperature or for 16 hr at 4°C. For detection, we used HRP-conjugated secondary antibodies and SuperSignal West Pico Chemiluminescent substrate.

In vitro transcription and translation {#s4-10}
--------------------------------------

In vitro transcription and translation reactions were performed as described previously in detail ([@bib59]). In vitro transcription used 5--20 ng/μl of purified PCR product in 40 mM HEPES pH 7.4, 6 mM MgCl~2~, 20 mM spermidine, 10 mM reduced glutathione, 0.5 mM ATP, 0.5 mM UTP, 0.5 mM CTP, 0.1 mM GTP, 0.5 mM CAP, 0.4--0.8 U/μl RNAsin and 0.4 U/μl SP6 polymerase and was performed for 1 hr at 37°C water bath. In vitro translation was performed using two rabbit reticulocyte lysate (RRL) systems: non-nucleased RRL was used to generate ribosomes collided at the stop codons of endogenous mRNAs (mostly ɑ- and β-globin) and RRL treated with micrococcal nuclease was used to translate WT and mutant EDF1 for purification. Translation reactions contained 33% by volume crude RRL (Green Hectares), 0.5 μCi/μl ^35^S-methionine, 20 mM HEPES, 10 mM KOH, 2 mM MgCl~2~, 40 μg/ml creatine kinase, 20 μg/ml pig liver tRNA, 12 mM creatine phosphate, 1 mM ATP, 1 mM GTP, 50 mM K(OAc), 2 mM MgCl~2~, 1 mM reduced glutathione, 0.3 mM spermidine and 40 μM of each amino acid except methionine. Each translation also contained mock (in case of non-nucleased RRL) or template-containing transcription reaction (nucleased RRL) which constituted 5% of the reaction by volume. Translations were for 20--45 min in a 32°C water bath.

Recombinant eRF1^AAQ^ production in *E. coli* {#s4-11}
---------------------------------------------

Recombinant eRF1^AAQ^ was produced as described before ([@bib7]) with minor modifications. In brief, *E. coli* strain BL21 DE3 pLysS was transformed with pRSETA/His~6~-TEV-eRF1^AAQ^ and grown on ampicillin-containing plates. Two flasks each containing 1 L ampicillin-containing LB were inoculated with 30% of the bacterial lawn from the plate and grown until 0.6 OD was reached. Induction of recombinant protein production was with 0.2 mM of IPTG for 2 hr at 37°C. Cells were sedimented by 30 min centrifugation in JA8.1 at 6000 rpm, washed once with 25 ml of ice-cold PBS buffer and spun again as above. Cell pellets were flash frozen in liquid nitrogen. For purification, cell pellets were thawed in room temperature water bath. Lysis was performed in 1xPBS supplemented with 250 mM NaCl, 10 mM imidazole, 1 mM DTT, 1x protease inhibitors cocktail by sonication. Lysate was precleared by 40 min spin at 18 000 rpm in JA 25.50 rotor and supernatant was applied to pre-equilibrated 1 ml of NiNTA resin (Qiagen). Resin was washed with 50 ml of lysis buffer and eluted with three bed volumes of elution buffer: 1xPBS, 250 mM NAcl, 250 mM imidazole, 1 mM DTT. The two elution fractions (2 ml) were pooled and dialysed against 1 L of dialysis buffer overnight (1xRNC, 10 mM imidazole, 10% glycerol, 1 mM DTT) in the presence of TEV protease in 1/50 ratio (weight/weight protein). Dialysate was spun for 15 min at max speed in tabletop microcentrifuge to remove any precipitate. Supernatant was applied to 1 ml of pre-equilibrated NiNTA resin to deplete any protein with uncleaved tag. Aliquots of the untagged eRF1^AAQ^ were flash frozen and stored in −80°C.

RT-qPCR {#s4-12}
-------

Flp-In T-REx 293 cells containing the (K^AAA^)~21~ stalling reporter at the FRT site were transfected with siRNAs as described in the figure legend. After \~72 hr, cells were induced for 6 hr with 1 μg/ml of doxycycline and harvested on ice. Total RNA extraction was performed using RNeasy Mini kit (Qiagen) according to manufacturer's protocol. Additionally, on column DNA digestion was perform to digest genomic DNA. 500 ng of total RNA was used to generate cDNA libraries using iScript cDNA synthesis kit (Biorad). Each sample was diluted 10-fold with nuclease free-water. Small quantities of all samples were pooled together and subsequently serially diluted to generate a standard curve. Each sample was additionally diluted 10-fold to ensure concentration within a standard curve. qPCR was performed using Viia 7 Real-Time PCR System (Thermo Fisher) and KAPA SYBR Fast qPCR reagents (KAPA Biosystems) according to manufacturer's protocol. The primer sequences are listed in the Key resources table. All pairs were annealed at 60°C and a melt curve was performed. Data was analysed using Quantstudio Real-Time PCR software v1.3. Values are normalised to the standard curve and against RPLP1 or GAPDH reference genes. Experiments include two biological replicates, each containing three technical replicates performed on two different sets of primers targeting the same transcript. Non parametric pairwise Mann-Whitney test was performed using Graphpad (Prism) software to asses statistical significance of the observed differences in the relative mRNA levels.
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**Acceptance summary:**

This article suggests a hitherto elusive mechanism implicated in resolving ribosome collisions that appears to be distinct from the previously described quality control mechanism wherein aborted translation is sensed by ZNF598. To this end, the authors provide evidence that recruitment of EDF1 to collided ribosomes triggers inhibition of translation initiation in cooperation with GIGYF2 and 4EHP. Future studies are warranted to establish the potential physiological role(s) of this EDF1-driven response to ribosome stalling.

**Decision letter after peer review:**

\[Editors' note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.\]

Thank you for submitting your work entitled \"Ribosome collisions trigger cis-acting feedback inhibition of translation initiation\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Ivan Topisirovic as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by a Senior Editor.

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife* at this stage.

There was general enthusiasm pertinent to the potential role of the EDF1-GIGYF2-4EHP axis in sensing and resolving ribosome collisions. Unfortunately, however, the reviewers felt that the ribosome profiling studies suffered from insufficient statistical rigor due to the lack of biological replicates. In addition, it was found that the mechanistic data corroborating the latter model were somewhat preliminary and/or open to alternative explanations. Specifically, it was thought that the analysis of ribosome profiling data should be improved by including independent biological replicates and statistically rigorous methodology. This should be complemented by orthogonal validation of ribosome profiling data and ZNF598-dependent stalls. In addition, experiments corroborating the proposed model would also benefit from sufficient replication. Important controls outlined in each of the reviewer\'s comments should also be included. Addressing issues raised regarding eS10 ubiqutination as well as the potential competition between GIGYF2-4EHP binding to EDF1 vs. ZNF598 would also be appreciated. The latter experiments should be carried out using more direct approaches (e.g. co-IP). Finally, excluding and/or considering alternative explanations pertinent to studies employing emetine was also thought to be warranted.

We realize that this news will be disappointing. If you plan to address these issues and resubmit this study to *eLife* as a new submission, we will try to expedite the review process by sending the manuscript to the same reviewers that reviewed the initial submission and include your responses to the reviewer comments from this round of evaluation. We hope you will find these comments constructive in planning your next steps.

Reviewer \#1

In this study, Juszkiewicz et al. provide evidence suggesting a previously unappreciated mechanism of resolving ribosome collisions centred on EDF1. This mechanism appears to be distinct form the quality control mechanism wherein aborted translation is sensed by ZNF598. To this end, the authors provide evidence that recruitment of EDF1 to collided ribosomes may inhibit translation initiation via recruitment of GIGYF2 and 4EHP. Based on these data, it is proposed that EDF1 examines mRNAs for increased ribosome density, followed by the recruitment of GIGYF2 to block initiation and facilitate resolving of ribosome collisions. Failure of this mechanism is suggested to be followed by induction of ZNF598-directed mechanism. Overall, it was found that this study is of broad potential interest as it describes a hitherto underexplored mechanism of resolution of ribosomal stalling and collisions. Notwithstanding general enthusiasm for the model, it was found that this study falls short when it comes to including a number of important controls as well as biological replicates to support authors\' conclusions. Specific comments are outlined below:

Major comments:

-- Several major issues were observed concerning inadequate scientific rigor, including insufficient number of replicates. It is stated in the legend of Figure 1---figure supplement 1 that ribosome profiling experiments were done in 2 technical replicates, which, if not a typo, suggest a single biological replicate. This precludes any meaningful statistical analysis. It is also expected that high reproducibility will be obtained from technical replicates, and it is thus not clear why technical replicates were used en lieu of biological replicates.

-- A number of additional issues were noted pertinent to ribosome profiling analysis:

\"To determine whether a subset of mRNAs are more dependent on ZNF598 than others, we tabulated the KO/WT ratio of CFr for each ORF. This value was plotted relative to that ORF\'s total dRPFs as an indicator of sampling depth, and hence reliability of the measurement (Figure 1C). 339 ORFs were higher (defined as ZNF598-dependent ORFs) and 159 ORFs lower than a significance interval defined by two standard deviations flanking a rolling mean\".

This is lacking any statistical rigor as there is no adjustment for multiple testing. It would be more appropriate to perform biological replicates and to statistics on these.

\"When normalized to the number of background rRNA reads as an internal control\...\"

Using rRNA to normalize is highly inadvisable as rRNA typically varies for a number of reasons. It also seems that the way rRNA reads are used to normalize the data, does not affect dRPFs to mRPFs ratio.

Figure 1---figure supplement 2: My opinion is that the correct approach here is to establish whether there are more dRPFs when TE adjusted for mRNA length. To this end, Y axis should represent dRPFs, while X axis should represent translational efficiencies calculated as residuals from a regression between mRPFs and mRNA levels (reads only from the coding region should be used). This will adjust for both length of the mRNA and the expression level.

\"One explanation for the absence of a correlation is if collisions on highly translated mRNAs are efficiently resolved by ZNF598-triggered disassembly. However, a matched ribosome profiling dataset from ZNF598 knockout (KO) cells showed a similar range of CFr and no correlation with TE (Figure 1---figure supplement 2A, orange dots). This indicates that highly translated mRNAs (as defined by high TE) neither show a higher than average basal collision frequency nor are they preferentially affected in ZNF598 KO cells\"

This seems as over-interpretation given how these effects were calculated, and the inherent noisiness of the assay. To make this claims RUST analysis should also be performed.

\"...would be more likely to occur on mRNAs with high ribosome density.\"

It seems equally plausible that local features of the CDS may explain this phenomenon.

\"Due to normalization, the above analysis cannot inform about any uniform and wholesale differences in collision frequency between WT versus KO cell\"

The authors should corroborate this statement as their data indicate largely uniform effects.

\"As exemplified by HNRNPU and RPS4X, some ORFs that did not score as hits when averaging CFr across the ORF nevertheless showed individual collision site(s) that are strongly dependent on ZNF598 (Figure 2C).\"

How were these identified? Do they occur more than by chance?

\"Such examples indicate that disome profiling is capable of identifying highly specific and strongly ZNF598-dependent stall sites with codon precision\".

Seems overstated without any systematic analysis and validation that these indeed represent true events.

\"Third, the collision frequency is remarkably similar across a wide range of translation efficiencies\"

Data to support this statement were found to be insufficient.

Several other weaknesses were observed:

-- \"In addition to ZNF598 as the most collision-specific interaction partner, we identified eight other candidate collision-specific proteins.\"

Can authors explain how were these proteins identified as candidates?

-- \"Only two of the candidates, EDF1 and GIGYF2, were collision-specific interactors in both WT and ZNF598 KO cells\"

How was this calculated/determined?

-- Figure 3D -- Western blot indicating the extent of ZNF598 depletion is missing.

Reviewer \#2

Ribosome stalling and collisions, as well ribosome-associated quality control have drawn considerable attention over the last several years. It was postulated that major substrate for this ribosome rescue pathway are ribosomes stalled on damaged and prematurely polyadenylated mRNAs. The stalls are resolved by no-go decay factors, Pelota-Hbs1, and ZNF598(Hel 2), however there are still gaps in the mechanism of this process. In this manuscript, Juszkiewicz and colleagues, demonstrate an interesting observation that the ribosome collisions may initiate translation initiation inhibition in cis independently of ZNF598 pathway.

Unfortunately, despite the clear support that EDF1 is involved in ribosome collisions and resolution of this process, most of the claims are not clearly or fully supported by the presented data.

1\) The complete analyses of ribosome profiling data and dRPF/mRPF ratio has multiple limitations. It is not clear whether these data are analyzed for the sequencing bias and normalization by dividing both sets with same rRNA background reads is problematic. The three conclusions drawn from these data are as such not supported.

2\) Authors never report that experiments shown in Figure 3C and Figure 5B are from the same set of data, but they clearly use the same blots in these two figures. Have authors did replicates of these experiments?

3\) It is not completely clear how eS10 gets ubiquitinated by ZNF598 in cells missing GIGYF2 (Figure 6). The supplement Figure 6 shows no recruitment of ZNF598 to poly-ribosomes in those same conditions with a rather massive recruitment in case of the WT cells. Authors argue that this could be due to transient interaction of ZNF598 in cells missing either EDF1 or GIGYF2. Is es10 ubiquitinated in HEK293 cells missing ZNF598, or Caco-2 and MCF-7 cells?

4\) Original report by Morita et al., 2012. has 4EHP-GIGYF2-ZNF598 complex as translational repressor with direct co-IPs between all components and especially between 4EHP and ZNF598 as well as GIGYF2 and ZNF598. Is EDF1 binding to GIGYF2-4EHP and competing with ZNF598? There is no co-IP studies shown on any components so the reader is left to believe on interactions through the polysome profiles or functional assays.

Reviewer \#3

The authors present a study on the dynamics of ribosome collisions and how modulations of the RQC pathway aim to resolve such aberrant events. By using a combination of disome-seq to identify collisions, clever reporter constructs and unbiased proteomics they shed light on different branching of the RQC pathway. Despite some important shortcomings pointed out in the following comments, the methods and conclusions are sound, the paper is well written, and it represent a strong contribution to the field.

1\) Steady-state RNA abundance in the different tested conditions has not been measured, making it impossible to appreciate possible changes in translation efficiency for the transcripts displaying collision events. The authors should show that such concern is not valid (the plot in Figure 2B does not represent a sufficient assessment), by experimental methods or analysis of other datasets. If not possible, the Authors should acknowledge this significant shortcoming, and revisit some of their conclusions where necessary.

2\) The authors should compare their findings with recent work outlining the crosstalk between translation initiation and the RQC: https://www.biorxiv.org/content/10.1101/792994v1

3\) The authors might want to explore the potential sequence/structure features underlying pausing collisions events and their potential in discriminating between ZNF598-dependent and other pausing events. Results from recent work on detecting pausing events should be considered (e.g. https://www.biorxiv.org/content/10.1101/746875v2 , https://www.biorxiv.org/content/10.1101/710061v1 , https://www.biorxiv.org/content/10.1101/710491v1).

4\) In the emetine treated samples, the percentage of dRPF reads mapping to the ORF greatly increases. Do the authors observe robust pausing/collisions outside coding regions in the different conditions, or do they represent possible contaminants?

5\) Figure 3C shows how both EDF1 and GIGYF2 migrate to the polysome fraction under emetine treatment. However, this might represent a more general phenomenon where many more protein complexes migrate to the polysome fraction. Can the author comment on this possibility?

\[Editors' note: further revisions were suggested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Ribosome collisions trigger cis-acting feedback inhibition of translation initiation\" for further consideration by *eLife*. Your revised article has been evaluated by Suzanne Pfeffer (Senior Editor) and a Reviewing Editor.

The manuscript has been improved but there are some remaining textual issues that need to be addressed before acceptance, as outlined below:

1\) It was thought that the authors should either tone down some statements or discuss alternative explanations of observed phenomena. In particular, the interpretation that EDF1 recruits GIGYF2 complex at collided ribosomes was found to be insufficiently supported by data. To this end, it was found that although the IP experiments support the role of EDF1 in stabilization of GIGYF2 complex binding to collided ribosomes, their role in its recruitment remains unclear. This should be clearly stated throughout the manuscript and depicted in the model shown in Figure 5. It was also thought that Figure 7 should be removed as this model would require further kinetic studies that, as we agree, are out of the scope of this study.

2\) Although highly appreciated, several issues were raised regarding frame-shifting studies. For instance, it appears that EDF1 depletion favours -1 frameshifting which cannot be fully explained by the collision model. Moreover, the authors cite studies that indicate that frameshifting should be in +1 direction. Discussion of these apparent discrepancies appears to be warranted. Potential effects of frameshifting on NMD activation should also be discussed. Finally, RFP signal and RFP/GFP ratios should be presented along with GFP for EDF1 knockdown and KO cells (Figure 4 and Figure 4---figure supplement 1) to further facilitate interpretation of results in Figure 6 and Figure 6---figure supplement 3.

3\) It was also thought that the authors should specify number of replicates and precise criteria for some statistical tests. For example, 1.6 fold threshold was found to be quite arbitrary, and the authors should clearly elaborate on criteria to use such cutoff. MS data should be made publicly available and identified factors that are enriched/depleted on collided ribosomes should be at least briefly discussed. The authors are are also encouraged to add all appropriate controls (e.g. showing that ZNF598 is indeed knocked out in the experiment in question rather than referring to previous publications where these lines were established)

4\) At times, interpretation of data was thought to require some clarification. Particularly, Figure 2---figure supplement 1A shows apparent increase in mRNA levels, albeit in the text the authors state that there is a lack of the potential mRNA abundance changes. To this end, it was thought that appropriate significance testing is required to corroborate the authors\' conclusions, and if it turns out that the changes in mRNA abundance are significant, this should be commented on. Moreover, it is argued that 4EHP, but not GIGYF2 depletion increases translation. However, considering the scale in Figures 2C vs. 2D, it appears that the changes are of comparable amplitude but in the opposite directions. Based on this, significance testing appears warranted.

5\) The authors are advised to verify some of the references. For instance in Mills et al., 2016 study does not appear to demonstrate ZNF598 loss during maturation of reticulocytes.

10.7554/eLife.60038.sa2

Author response

\[Editors' note: the authors resubmitted a revised version of the paper for consideration. What follows is the authors' response to the first round of review.\]

We appreciate the overall enthusiasm for our discovery of an EDF1-GIGYF2-4EHP mechanism of collision-specific translation repression. A large majority of the concerns related to inadequate analysis of a ribosome profiling experiment that aimed to provide a survey of collisions across the transcriptome. Because this experiment is tangential to the key findings of a new collision dependent response, we and the handling editor agreed that the study would be better if the profiling was omitted and the rest of the manuscript strengthened. In the response below, we address the non-profiling comments; the comments relating to profiling are no longer relevant.

> Key issues identified by the Editor:
>
> 1\) Is EDF1 binding to GIGYF2-4EHP and competing with ZNF598? Moreover, what is the status of GIGYF2 complexes (with ZNF598 vs. EDF1) in emetine treated vs. control cells? Is ZNF598GIGYF2-4EHP still preserved in EDF1 knockout cells? Is interaction between ZNF598 and 4EHP (Morita et al., 2012, MCB) affected in GIGYF2 knockout cells? IP experiments were thought to be an appropriate approach here.

Using co-IP experiments, we examined the potential interactions between EDF1, GIGYF2, and ZNF598 to complement previous experiments by Morita et al., 2012. The IPs were performed from the ribosome-free cytosolic fraction to avoid co-precipitation due to bridging via polysomes. As shown in the new Figure 5, we find that ZNF598 interacts with GIGYF2, but that EDF1 does not interact with either. The absence of EDF1 interaction was verified with two different tags. The ZNF598-GIGYF2 interaction is retained in EDF1 knockout cells, further arguing that EDF1 is not an integral part of this complex away from the ribosome. Earlier work established that the ZNF598 interaction with 4EHP is via GIGYF2 (Figure 5B in Morita et al., 2012). Here, mutation of the 4EHP interaction motif in GIGYF2 prevented co-IP of 4EHP by ZNF598 despite recovery of GIGYF2. Because the GIGYF2-4EHP interaction is well established and validated with mutants, it was not re-explored in our experiments. Collectively, these findings show that free in the cytosol, ZNF598 interacts with GIGYF2, which interacts with 4EHP. This complex does not appear to include or require EDF1.

Interactions among these proteins on the ribosome cannot be deduced by co-IP because the ribosome and/or mRNA may bridge proteins that are nowhere close to each other. Nevertheless, we can observe by co-fractionation that EDF1, GIGYF2 (Figure 1B), and ZNF598 (Figure 6---figure supplement 2) are all selectively on collided ribosomes. While this finding by itself does not demonstrate they are all together on the same collided ribosome, this is a likely interpretation for the following reasons:

i\) GIGYF2 interacts with ZNF598 and 4EHP off the ribosome (Figure 5, as described above), indicating that they are probably recruited together to collisions.

ii\) Recruitment of GIGYF2 to collisions is impaired without EDF1 (Figure 4B) arguing that GIGYF2 is recruited to ribosomes that contain EDF1.

iii\) Recruitment of ZNF598 to collisions is impaired without GIGYF2 or EDF1 (Figure 6---figure supplement 2) arguing that ZNF598 is recruited to ribosomes containing these factors.

Based on the collection of these data, together with the finding that EDF1 recruitment to collisions does not depend on ZNF598 (Figure 1C) or GIGYF2 (Figure 5---figure supplement 1), we conclude that EDF1 engages collided ribosomes and facilitates the recruitment of pre-formed ZNF598GIGYF2-4EHP complexes (see diagram in Figure 5E). The spatial arrangement of this complex on the ribosome will require structural analysis that is beyond the scope of this study.

> 2\) How is eS10 ubiquitinated by ZNF598 in cells missing GIGYF2 (Figure 6)? The supplement Figure 6 shows that ZNF598 is not recruited to polysomes in the latter cells. It is argued that this may be due to transient interaction of ZNF598. However, it was thought that direct experimental evidence corroborating this tenet should be provided.

Long exposures of the immunoblots show that although weak, ZNF598 does interact selectively with collided ribosomes even in cells lacking GIGYF2 or EDF1 (Figure 6---figure supplement 2). This is consistent with a transient interaction mediating the observed eS10 ubiquitination. To verify this conclusion and exclude the possibility that another ligase ubiquitinates eS10, we analysed eS10 ubiquitination upon ZNF598 depletion in wild type cells and those lacking GIGYF2 (Figure 6C). The complete loss of ubiquitinated eS10 in each case demonstrates that ZNF598 is the sole E3 ligase for eS10, arguing that indeed a weak interaction is sufficient for ubiquitination to proceed effectively. This is now explained in the revised text that accompanies the above new experiments.

> 3\) MbF1 (yeast EDF1 homolog) is thought to prevent frameshifting in yeast cells on stalled ribosomes (Wang et al., 2018). Is there more frameshifting with reporters in EDF1-depleted Hek293 cells relative to controls?

We analyzed this in some detail using four different reporters: (i) a weakly stalling poly(A) sequence; (ii) the Xbp1 stalling sequence; (iii) a strong-stalling variant of Xbp1; (iv) a weakstalling variant of Xbp1. As detailed in Figure 3 and its accompanying two supplements, depletion of EDF1 results in increased frameshifting at the Xbp1 stall and its strong-stalling variant, but not at the weaker stalling Xbp1 mutant or the weakly stalling poly(A) sequence. As discussed in the relevant parts of the text, we conclude that stalling and the ensuing ribosome collisions cause frameshifting (as in yeast), and that EDF1 mitigates this similar to Mbf1 in yeast (although there are clearly differences, as discussed in the text).

> Reviewer \#1
>
> -- \"In addition to ZNF598 as the most collision-specific interaction partner, we identified eight other candidate collision-specific proteins.\"
>
> Can authors explain how were these proteins identified as candidates?
>
> -- \"Only two of the candidates, EDF1 and GIGYF2, were collision-specific interactors in both WT and ZNF598 KO cells\"
>
> How was this calculated/determined?

Sorry for not explaining this. We have now amended the text to explicitly indicate how many total proteins were identified in the mass spectrometry experiment (\~600), what criteria were used to identify candidates (1.6-fold enrichment on collided polysomes relative to both untreated and fully stalled polysomes), and what further criteria led us to EDF1 and GIGYF2 (1.6-fold enrichment on collided ribosomes even in ZNF598 knockout cells).

> -- Figure 3D -- Western blot indicating the extent of ZNF598 depletion is missing.

We apologise for the confusion. These are CRISPR-mediated knockout cells that were previously validated to have no detectable ZNF598 (Juszkiewicz and Hegde, 2017).

> Reviewer \#2
>
> Authors never report that experiments shown in Figure 3C and Figure 5B are from the same set of data, but they clearly use the same blots in these two figures. Have authors did replicates of these experiments?

We apologise for this oversight. In a previous draft of this manuscript, Figure 3C and 5B were part of a single figure from an experiment that was later presented in two parts. That is why the GIGYF2 and RACK1 blots were the same (sorry for not making this explicit in the respective legends). To avoid any concern or confusion, one of the figures (now Figure 4B) has been replaced with a different version of that same experiment.

> It is not completely clear how eS10 gets ubiquitinated by ZNF598 in cells missing GIGYF2 (Figure 6). The supplement Figure 6 shows no recruitment of ZNF598 to poly-ribosomes in those same conditions with a rather massive recruitment in case of the WT cells. Authors argue that this could be due to transient interaction of ZNF598 in cells missing either EDF1 or GIGYF2. Is es10 ubiquitinated in HEK293 cells missing ZNF598, or Caco-2 and MCF-7 cells?

We have now verified that the ubiquitination of eS10 is completely dependent on ZNF598 in both wild type cells and in cells lacking GIGYF2 or EDF1 (Figure 6C). Thus, the ubiquitination must be due to transient interactions that do not result in stable co-fractionation through sucrose gradients. Consistent with this conclusion, long exposures of the immunoblots show that although weak, ZNF598 does interact selectively with collided ribosomes even in cells lacking GIGYF2 or EDF1 (Figure 6---figure supplement 2).

> Original report by Morita et al., 2012. has 4EHP-GIGYF2-ZNF598 complex as translational repressor with direct co-IPs between all components and especially between 4EHP and ZNF598 as well as GIGYF2 and ZNF598. Is EDF1 binding to GIGYF2-4EHP and competing with ZNF598? There is no co-IP studies shown on any components so the reader is left to believe on interactions through the polysome profiles or functional assays.

We have now added co-IP experiments to our study showing that GIGYF2 interacts with 4EHP and ZNF598, and that EDF1 is not part of this complex away from the ribosome (Figure 5; see detailed reply to the Editor's comments above).

> Reviewer \#3
>
> The authors should compare their findings with recent work outlining the crosstalk between translation initiation and the RQC: https://www.biorxiv.org/content/10.1101/792994v1

This is now cited at a few key points in the paper. We avoid extensive comparison or discussion as this study has not undergone peer review and might change in the process.

> The authors might want to explore the potential sequence/structure features underlying pausing collisions events and their potential in discriminating between ZNF598-dependent and other pausing events. Results from recent work on detecting pausing events should be considered (e.g. https://www.biorxiv.org/content/10.1101/746875v2 , https://www.biorxiv.org/content/10.1101/710061v1 , https://www.biorxiv.org/content/10.1101/710491v1).

As noted in the overall reply to the Editor, we have omitted our own ribosome profiling analysis. Instead, we cite the above studies as evidence for widespread pausing and collisions.

> Figure 3C shows how both EDF1 and GIGYF2 migrate to the polysome fraction under emetine treatment. However, this might represent a more general phenomenon where many more protein complexes migrate to the polysome fraction. Can the author comment on this possibility?

This is now clarified in the text where we explain that extensive proteomic analysis shows that the vast majority of the \~600 detected proteins do not show this behavior. Furthermore, of these \~600 proteins, only EDF1 and GIGYF2 showed this behavior in both wild type and ZNF598 cells, which is why these were pursued in downstream experiments. Sorry for not explaining how uniquely specific these two hits proved to be.

\[Editors' note: what follows is the authors' response to the second round of review.\]

> The manuscript has been improved but there are some remaining textual issues that need to be addressed before acceptance, as outlined below:
>
> 1\) It was thought that the authors should either tone down some statements or discuss alternative explanations of observed phenomena. In particular, the interpretation that EDF1 recruits GIGYF2 complex at collided ribosomes was found to be insufficiently supported by data. To this end, it was found that although the IP experiments support the role of EDF1 in stabilization of GIGYF2 complex binding to collided ribosomes, their role in its recruitment remains unclear. This should be clearly stated throughout the manuscript and depicted in the model shown in Figure 5. It was also thought that Figure 7 should be removed as this model would require further kinetic studies that, as we agree, are out of the scope of this study.

We have changed the wording in the text to avoid making any claims about EDF1 directly recruiting the GIGYF2 complex to collided ribosomes. Instead, we are cautious to always state that EDF1 "stabilizes" or "facilitates stable engagement" or "facilitates stable binding" of GIGYF2 with collided ribosomes. These are accurate descriptions based on the data: GIGYF2 is selectively associated with collided ribosomes (Figure 1 and Figure 1---figure supplement 1), and this association is impaired in cells lacking EDF1 (Figure 4B; Figure 5C, lanes 3-6). Importantly EDF1 is itself specific for collided ribosomes and this does not depend on ZNF598 (Figure 1) or GIGYF2 (Figure 5---figure supplement 1). Furthermore, a point mutation in EDF1 that impairs its ribosome binding (Figure 4C) is also impaired in translation repression at stalls (Figure 4D), an effect that is mediated by GIGYF2. These findings support the conclusion that EDF1, and specifically its ribosome binding, is needed for effective function of GIGYF2. In the Discussion, we note the two alternative interpretations of these data: (i) a direct model where EDF1 provides part of a binding site for the GIGYF2 complex on collided ribosomes; (ii) an indirect model where EDF1 engagement of collided ribosomes changes the ribosome complex in a way that favours the bound state of the GIGYF2 complex.

We have edited the diagram in Figure 5 to be agnostic to either model. Here, and in Figure 7, we depict all of the factors associated with collided ribosomes rather than showing a hypothetical order of binding. Figure 5 further depicts that off the ribosome, interactions between ZNF598GIGYF2-4EHP are observed, which is supported by the co-IP data in Figure 5 and earlier cited work. In the text our wording is now more cautious: "Although we cannot know the order of binding to the ribosome from these data, we speculate that EDF1 binding may occur first because it is \~50 fold more abundant than either GIGYF2 or ZNF598 (Itzhak et al., 2016)." We are similarly circumspect in the Discussion section on this issue.

We have opted to retain Figure 7 because it is helpful to illustrate for readers what we think is happening. To alleviate the reviewers' concern, we have now edited the Discussion to better explain our rationale for proposing each aspect of our model. The main point of speculation is that re-starting elongation after an incidental collision is faster than ubiquitination and helicase-mediated ribosome disassembly. We now provide appropriate references and cite specific time ranges for the appropriate reactions. Elongation reactions take between \~200 ms to 4 seconds, while the sum of ZNF598- and ASCC-mediated reactions is likely to take minutes. We are also careful to state that although we have not measured the rates of all binding and enzymatic reactions, our estimates of these are based on sound and well-established biochemical principles. All other aspects of the model are well supported by data, which we will not enumerate again here.

> 2\) Although highly appreciated, several issues were raised regarding frame-shifting studies. For instance, it appears that EDF1 depletion favours -1 frameshifting which cannot be fully explained by the collision model. Moreover, the authors cite studies that indicate that frameshifting should be in +1 direction. Discussion of these apparent discrepancies appears to be warranted. Potential effects of frameshifting on NMD activation should also be discussed. Finally, RFP signal and RFP/GFP ratios should be presented along with GFP for EDF1 knockdown and KO cells (Figure 4 and Figure 4---figure supplement 1) to further facilitate interpretation of results in Figure 6 and Figure 6---figure supplement 3.

The mechanistic basis of frameshifting at collisions is not known. At this point, it remains a correlative observation, both in our study and in two earlier studies. The earlier studies used different reporters, a different organism (yeast), and different means of stalling the ribosome. The mechanism of stalling is clearly influenced by organism (since di-codons or stem-loops that stall in yeast have little or no effect in mammals), so direct comparisons between yeast and mammals have not been possible. Importantly, the mechanism of stalling seems to influence frameshifting: di-codons seem to prefer +1, whereas a stem-loop permits both -1 and +1 (Wang et al., 2018). Thus, on the basis of earlier studies in yeast, there was no reason to necessarily expect any particular result in mammalian experiments that use qualitatively different mechanisms of stalling. Thus, there are no discrepancies; simply a set of difficult-tocompare observations using different reagents, methods, and organisms to probe a poorly understood phenomenon. We now state that our results "roughly approximate" recent observations in the yeast system, then explicitly highlight the above issues.

We also mention that an appreciable role for NMD can be excluded because the GFP signal does not change with the frameshifting constructs despite clearly showing premature termination (i.e., the RFP signal is markedly reduced). This is consistent with past work showing that in mammals, a downstream exon junction complex is typically needed to trigger NMD, so it would not be expected for an intronless reporter. Finally, the requested individual GFP, RFP, and ratio plots of the experiments in Figure 4 are provided as a new supplement to Figure 6 so they can be compared by any interested reader (Figure 6---figure supplement 4).

> 3\) It was also thought that the authors should specify number of replicates and precise criteria for some statistical tests. For example, 1.6 fold threshold was found to be quite arbitrary, and the authors should clearly elaborate on criteria to use such cutoff. MS data should be made publicly available and identified factors that are enriched/depleted on collided ribosomes should be at least briefly discussed. The authors are are also encouraged to add all appropriate controls (e.g. showing that ZNF598 is indeed knocked out in the experiment in question rather than referring to previous publications where these lines were established)

The number of replicates as well as other important information related to data acquisition and analysis for each experiment is available in the Materials and methods section. The complete quantitative mass spectrometry data (as an annotated Excel file) is provided with the paper, just as it was provided with the initial submission and the revision. The raw files have been uploaded to the PRIDE database by our mass spectrometry facility. Dotted lines indicating 3 standard deviations from the mean have been added to the graphs in Figure 1 to provide a point of reference. EDF1 and GIGYF2 were chosen for further study because they are the two most collision-specific proteins in both wild type and ZNF598 knockout cells. This reason is stated in Results paragraph one. A cut-off or threshold is irrelevant, since our choice to study these was because they were the most enriched, which would be the case regardless of any chosen threshold.

Other proteins that we did not study further are not discussed because we have nothing productive to say about them. We only labelled them on the graph in Figure 1A because they were all provisional candidates until we did the secondary analysis in Figure 1B that highlighted EDF1 and GIGYF2. Because we provide the full dataset, any interested colleague can read about them and pursue them as desired.

The absence of ZNF598 in knockout cells is documented in Figure 1 and in the MS dataset provided, where it is preferentially detected in wild type, but not knockout cells. This should alleviate any concern that the cell line has somehow reverted since our previous publication, which is also clear from its characteristic phenotype (Figure 3C and Figure 6---figure supplement 3). The knockdowns and knockouts of all other components are documented with immunoblots within the paper.

> 4\) At times, interpretation of data was thought to require some clarification. Particularly, Figure 2---figure supplement 1A shows apparent increase in mRNA levels, albeit in the text the authors state that there is a lack of the potential mRNA abundance changes. To this end, it was thought that appropriate significance testing is required to corroborate the authors\' conclusions, and if it turns out that the changes in mRNA abundance are significant, this should be commented on. Moreover, it is argued that 4EHP, but not GIGYF2 depletion increases translation. However, considering the scale in Figures 2C vs. 2D, it appears that the changes are of comparable amplitude but in the opposite directions. Based on this, significance testing appears warranted.

No differences are seen in mRNA levels by statistical comparisons, and this is stated in the legend. Regarding the second point, the reviewer appears to have mis-interpreted the data, perhaps by overlooking the fact that Figure 4C, 4D, and 4E are performed in different genetic backgrounds. Both GIGYF2 depletion and 4EHP depletion each increases translation in wild type cells (Figure 4C). Figure 4D documents that 4EHP depletion does not increase translation further in GIGYF2 knockout cells, providing genetic evidence that they act in the same pathway. Figure 2E documents that GIGYF2 depletion and 4EHP depletion each increases translation in ZNF598 knockout cells, illustrating that ZNF598 is not required for this effect.

> 5\) The authors are advised to verify some of the references. For instance in Mills et al., 2016 study does not appear to demonstrate ZNF598 loss during maturation of reticulocytes.

Mills et al. did not study ZNF598 specifically, but they do provide ribosome profiling datasets of reticulocytes. Inspection of this dataset reveals that footprints corresponding to ZNF598 are not detected in reticulocytes. Importantly, footprints of other mRNAs that are similar in abundance to ZNF598 in a pre-reticulocyte cell line are detected in reticulocytes. This supports the idea that ZNF598 mRNA is reduced or absent in reticulocytes, consistent with the absence of ZNF598 protein in reticulocyte lysate as documented in Juszkiewicz et al., 2018, which is cited together with Mills et al., 2016.

[^1]: These authors contributed equally to this work.
